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The liver is one of the main organs of endodermal origin. Most knowledge of liver 
development is obtained from reverse genetics and explants culture approaches 
performed on mice and chick. However, various gaps still exist in the whole picture of 
liver organogenesis due to limitations of such methodologies and early lethality of liver 
defects. Zebrafish, a recently chosen model for the study of vertebrate development, is 
particularly suitable for studying liver organogenesis via forward genetics. To take 
advantage of the zebrafish system for the investigation of the molecular mechanisms of 
liver development, we carried out a middle-scale genetic screen for liver defective 
mutants and adopted the map-based cloning method for the identification of mutated 
genes. 
By exploiting the polymorphisms exhibited in 226 pairs of simple sequence length 
polymorphism (SSLP) markers and polymorphic mapping families, the bulk segregation 
analysis (BSA) protocol has mapped one of the small liver mutants, sq163 to linkage 
group 12. From ~6800 meiotic events, subsequent detailed mapping in combination with 
candidate gene approach have identified a T to A mutation in the ribosomal biogenesis 
protein (Bms1l) gene, which results in the L154 to Q154 substitution in a GTPase motif in 
Bms1l. Genetic evidence from co-segregation analysis, morpholino knockdown and 
phenotypic rescuing experiment unequivocally demonstrated that the bms1lsq163 mutation 
is responsible for the small liver phenotype. Bms1l is a key component in the 40S 
ribosomal biogenesis pathway that recruits many other ribosomal proteins onto the pre-
ribosome-rRNA complex. Its role in this universal mechanism of ribosomes production 
has been well studied and established in yeast. The positional cloning of sq163 is the first 
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genetic indication of Bms1l possibly playing a specific function in vertebrate liver 
organogenesis. Preliminary phenotypic characterization of the mutant using digestive 
organ specific molecular markers suggested that liver budding and initial growth are 
affected in the homozygous mutant which continues to impinge on subsequent expansion 
of the liver, as well as other digestive organs such as the intestine and pancreas, resulting 
in their retardation after 3dpf. Whole mount in situ hybridization on wildtype embryos 
showed that bms1l is enriched in the entire digestive tract and its accessory organs, 
consistent with the bms1lsq163 mutant phenotypes. Proliferation assay suggests that 
impairment of hepatoblasts proliferation is one of the consequences of bms1lsq163 that 
give rise to the small liver phenotype. Excitingly, one of the main interacting partners in 
the ribosomal biogenesis pathway, rc1l, was shown to share highly similar expression 
patterns with bms1l in the digestive organs, further suggesting that the ribosomal pathway 
is necessary for zebrafish liver development.  
While both examination of earlier mutant embryos with more extensive markers and 
investigation at the cellular and biochemical level will be necessary to reveal further 
insights into the functional consequences of bms1lsq163, the work reported in this thesis 
has demonstrated the possible involvement of a seemingly housekeeping gene in specific 
development process such as liver formation, of which eventually may be instrumental in 
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Chapter 1  Introduction 
 
Liver is the largest internal organ found in vertebrate body which is formed together with 
other organs via a process called organogenesis. This chapter introduces the topic of liver 
organogenesis by focusing on the following key questions: how it begins (germ cell 
origin), what happens along the way (stages and mechanisms) and where it ends up 
(destinations and functions). Through summarizing the results obtained from tissue 
transplantation, genetic, biochemical, cellular and molecular data accumulated in the past 
30 years obtained from frog, chick and mouse, the commonly accepted five stages of 
liver organogenesis are concluded as such: (i) competency acquisition, (ii) cell fate 
specification, (iii) bud initiation, (iv) bud expansion and (v) cell differentiation. Later in 
the chapter the exploitation of an emerging model, the zebrafish, leading to the feasibility 
of large-scale genetic screenings and the significant findings so far will be reviewed. 
Combining these diverse but related lines of evidence allows the comparison and 
complementation of data, presents what has been achieved in the field so far, the current 
research directions and eventually lays down the rationales of my project in relevance to 




1.1 Germ layers and organogenesis  
In vertebrates, the development of the zygote into an embryo proceeds through specific 
recognizable stages of blastula, gastrula, and organogenesis. Typically, the blastula stage 
features a fluid-filled cavity, the blastocoel, surrounded by a sphere or sheet of cells, 
collected on top, called the blastomeres. During gastrulation these cells undergo drastic 
but coordinated processes of cell division, invasion, and/or migration to form either two 
(diploblastic) or three (triploblastic) tissue layers. In triploblastic organisms (all higher 
and intermediate animals (from flat worms to humans)), the three germ layers are 
called endoderm, ectoderm and mesoderm. However, the position and arrangement of the 
germ layers are highly species-specific, they define the type of embryo eventually 
produced. In vertebrates, a special population of embryonic cells called the neural crest 
has been proposed as a "fourth germ layer", and is thought to have been an important 
novelty in the evolution of head structures (http://en.wikipedia.org/wiki/Embryo). 
During organogenesis, the ectoderm, endoderm, and mesoderm develop into organs of 
the organism. Based on cell fate mapping experiments, the destinations of these germ 
layers across the embryo have been determined. The ectoderm produces tissues within 
the epidermis and helps in the formation of neurons within the brain, and melanocytes. 
The mesoderm leads to the production of cardiac muscle, skeletal muscle, smooth muscle, 
tissues within the kidneys, gut and red blood cells. In addition to the general list, the 
mesoderm of a developing vertebrate also differentiates into the 
followings: Chordamesoderm, Paraxial mesoderm, Intermediate mesoderm, Lateral plate 
mesoderm (LPM). Essentially, the formation of a mesoderm results in the formation of 
some kind of a body cavity called the coelom. Organs formed inside a coelom can freely 
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move, grow, and develop independently of the body wall while fluid cushions protect 
them from shocks (Blitz et al., 2006). 
ier, 2002).  
The endoderm, the focus of this thesis, is formed when cells migrating inward along the 
primitive gut to form the inner layer of the gastrula. It consists at first of flattened cells, 
which subsequently become columnar and polarized. It forms the epithelial lining of the 
whole of the digestive tube except part of the mouth, pharynx and the terminal part of 
the rectum. Expectedly, it also contributes to the cell linings of all the glands which open 
into the digestive tube, including those of the liver and pancreas, the epithelium of 
the auditory tube and tympanic cavity, the trachea, bronchi, and alveoli of the lungs, 
the urinary bladder and part of the urethra, and the follicles of the thyroid gland 
and thymus (Stain
However although well defined by fate maps, due to the close proximity and the nature of 
the mechanistic movements among germ layers, especially between mesoderm and 
endoderm, an internal organ may be constituted by more than one origin of germ layer.  
In addition, similar to the majority events happening during development, organogenesis 
is an orchestrated process where the different germ layers work cooperatively and 
collaboratively, mediated by a network of cross-talking among signaling molecules and 
transcription factors. Acting together with the cells’ developmental potential or 
competence to respond, they prompt further differentiation of organ-specific cell types. 
 
1.2 Liver: Structure and Functions 
1.2.1 The liver structure 
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The appreciation of the multifaceted functions of liver is dependent on the understanding 
of its structure. The structure of liver can be discussed in three aspects: the hepatic 
vascular system, the biliary system and the three dimensional arrangements of the liver 
cells bound by these two systems. The information on liver structure and functions 
discussed below is extracted and summarized from www.gastroresource.com/gitextbook/ 
En/Chapter14, www.essortment.com/all/liverscellsstr_ricl.htm and student.britannica. 
com/comptons/ article-203966/liver. 
 
1.2.1.1 The hepatic vascular system 
This system handles blood flow. The liver receives blood from two sources. A majority 
of (approximately 75%) the liver's blood supply is venous blood and supplied by the 
portal vein that drains the blood from the intestinal system (including the pancreas, 
stomach and the spleen). This source is rich in nutrients but poor in oxygen. The liver 
processes the nutrients and by-products of food digestion while the low oxygen level is 
being boosted up by the remaining oxygenated blood supply (about 25%) coming fresh 
from the hepatic artery of the heart (Figure 1-1). The blood flow from the terminal 
branches of the hepatic portal vein and hepatic artery coalesces into sinusoids in the liver 
and drains into the central vein in each lobule (Figure 1-2A). The hepatic vein collects the 
blood from the central vein and leaves the liver and links to the inferior vena cava.  
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 Figure 1-1 Hepatic structure of the human liver showing the vascular and biliary system. 
Adapted from http://www.moondragon.org/health/disorders/gallbladder.html 
 
 
The biliary system 
The biliary system processes the flow of bile, a green alkaline fluid secreted 
by hepatocytes which aids in digestion. The system consists of a series of channels and 
ducts that transport bile from the liver into the small intestine. The bile canaliculus is the 
first channel in the biliary system. It is formed by grooves between tight junctions on the 
contact surface of adjacent hepatocytes. The bile secreted into canaliculi progressively 
flows into ductules, interlobular bile ducts and then larger hepatic ducts (Figure 1-2A). 
The bile ducts coalesce to form the left and right hepatic ducts. The common hepatic duct 
drains the bile from the left and right hepatic ducts and joins with the cystic duct from the 
gallbladder to form the common bile duct. The common bile duct merges with the main 
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pancreatic duct in the hepatopancreatic ampulla that enters the duodenum at the major 




Figure 1-2 (A) Microscopic anatomy of the human liver highlighting (B) the lobule 




1.2.1.2 The three dimensional architecture of the liver 
A basic unit of the liver is a polygonal column called liver lobule. The corners between 
polygonal lobules are portal spaces, where portal triads (portal vein, artery, bile duct and 
a later discovered component – lymphatic vessels) are located (Figure 1-2A, B). 
Radiating from the center to the lobule periphery are branching, anatomizing plates of 
hepatocytes, one or two cells thick, separated by the liver sinusoids (Figure 1-2A, B).  
Sinusoids are vascular channels lined with highly fenestrated endothelial cells. The 
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endothelial cells have no basement membrane and are separated from the hepatocytes by 
the space of Disse. Several types of cells are residents in the sinusoids or the space of 
Disse: Kupffer cells, stellate cells (Ito cells) and Pit cells. Microvilli from the hepatocytes 
also protrude into this space. With such a vascular arrangement, blood plasma can easily 
percolate through the sinusoidal fenestrations into the space of Disse making intimate 
contact with hepatocytes, maximizing the exposure of the cells to blood flow and the bile 
canaliculi hence facilitating exchange. At the cellular level, it is quite surprising that 
being such an important and big organ, the liver harbors only a relatively small number of 
differentiated cell types. Hepatocyte, a polarized epithelial cell, is the main cell type 
accounting for 60% of all liver cells. It is the most versatile cell type in the human body 
as it is responsible for all the main liver functions. This is likely to explain the 
unexpected low variety of cell types present in the organ.  Kupffer cells, cholangiocytes 
(the epithelial cells of the bile duct), stellate (Ito) cells and endothelial cells make up the 
rest cell population in the liver. 
 
1.2.2 The liver functions 
The functions of the liver are highly supported by its 3D cellular architecture. Having 
such a complex anatomical make up as discussed above, the liver undeniably carries out 
many essential functions. With its unique position as an interface between blood 
returning from the digestive tract (the portal venous system) and the rest of the 
bloodstream (via the hepatic venous system), it must play key roles in processing all the 
nutrients and by-products of food digestion and conditioning blood through detoxification 
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and endocrine activities respectively, before they are released back into the general 
systemic circulation.  
Making up as much as 60% of the total number of cells in the liver, the hepatocytes 
understandably play critical roles in the metabolism of carbohydrate, lipid and protein. As 
the body’s main energy source, the narrow range of glucose level that can exist in the 
blood is strictly regulated by three processes: glycogenesis (to synthesize glycogen from 
excess glucose in the blood), glycogenolysis (to depolymerize glycogen and export of 
glucose back into the blood) and gluconeogenesis (to synthesize glucose out of amino 
acids and non-hexose carbohydrates when hepatic glycogen reserves become exhausted). 
In lipid metabolism, the liver is extremely active in directly oxidizing triglycerides and 
exports large quantities of acetoacetate into blood to produce energy. At the same time, it 
is also responsible for the conversion of excessive carbohydrates and proteins into fatty 
acids and triglyceride, and exports them to adipose tissue. In protein metabolism, the 
most critical function of the liver is the deamination and transamination of amino acids. It 
converts non-nitrogenous parts into glucose or lipids and transforms the ammonia into 
urea to exit the body in urine.  
As a big vascularized organ, liver serves as a reservoir for a multitude of substances. The 
synthesized glycogen is stored in the hepatocytes as reserved energy. Lipid droplets can 
be found in the hepatocytes and Ito cells, which are fat-storing cells in the space of Disse. 
They also synthesize hepatic growth factor and are involved in the production of the 
extracellular matrix (collagen). The liver can also store iron and vitamins. By-products 
come with metabolism. Being a major site of metabolism, the liver performs excretion in 
two ways: By-products in the bile (such as bilirubin, a breakdown product of hemoglobin 
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in Kupffer cells) enter the intestine, and then leave the body in the feces. By-products in 
the blood (such as urea) are filtered out by the kidneys, and then leave the body in the 
urine. 
Before excretion, the liver needs to process nutrients and filter blood, making 
detoxification one of the other unavoidable functions of the liver: accidentally ingested 
drugs and poisonous substances are broken down in the liver and excreted as harmless 
by-products into the bile and thus get eliminated from the body or back into the blood. It 
also collects and breaks down body wastes including hormones such as insulin and 
hemoglobin.  
Besides that, the liver is essentially a ‘factory’. It manufactures about as much as half of 
the body’s cholesterol, which are either packaged with lipoproteins and get transported to 
the rest of the body for example to make vital part of every cell membrane, or get 
excreted in bile as cholesterol or bile acids after conversion. Cholesterol is also a 
necessary component in certain hormones, including estrogen, testosterone, and the 
adrenal hormones. 
Being also the largest gland in the body, the liver notably has very important endocrine 
functions. It secretes a whole range of serum proteins, such as albumin, fibrinogen, 
prothrombin, as well as protein C, protein S and antithrombin, which are crucial in 
maintaining homeostasis of the body. The liver’s major exocrine function is to assist 
digestion by generating large amounts of acidic bile into the digestive tract via hepatic 
duct. The low pH of the bile also aids in the absorption of fats and fat-soluble vitamins in 
the small intestine. 
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The liver also plays a role in immunity. The reticuloendothelial system of the liver 
contains many immunologically active cells, acting as a 'sieve' for antigens carried to it 
via the portal system. For example, the Kupffer cells are macrophages (derived from 
monocytes) that are permanent residents within the lumen of the sinusoids. They function 
in the filtration of the portal blood through phagocytosis of old red blood cells and 
bacteria. The highly mobile Pit cells are natural killer lymphocytes attached to the 
endothelium.  
One of the other significant functions of the liver is the capability of natural regeneration 
of lost tissue. In mouse, the whole liver can be recovered from as little as 25% remnants 
within 7 days, after a surgical process, hepatectomy. This is predominantly due to the 
nature of hepatocytes, which behave like unipotent stem cells. Recently there is also 
emerging evidence indicating the existence of bipotential hepatic stem cells, called oval 
cells, which can differentiate into either hepatocytes or cholangiocytes (bile duct cells). 
The implication of this offers the possibility of liver therapy during severe liver damage. 
To end an unexhausting list, the fetal liver also serves as a site for haematopoiesis by 
mid-gestation. With such a diverse inventory of functions, there is only a small number of 
cell types found in liver. Approximately 60% of cells in the adult liver are hepatocytes 
and the remaining cells are cholangiocytes (bile duct cells), Kuppfer cells, stellate cells 
and some endothelial cells. Apart from the array of important functions that it executes, 
this low complexity makes the liver a very attractive organ for the dissection of the 
organogenesis process. 
 
1.3 Liver organogenesis  
 10
1.3.1 Liver is an endodermal-derived organ 
The endoderm is one of the three germ layers established during gastrulation. In mouse 
embryo, embryonic development stages are defined by embryonic day (E). At embryonic 
day 6 (E6), gastrulation starts with the formation of the primitive streak at the posterior of 
the epiblast (also known as the primitive/primary ectoderm). The endoderm precursor 
cells migrate through the primitive streak and displace the visceral endoderm which 
surrounds epiblasts (Wells and Melton, 1999). The visceral endoderm is an 
extraembryonic tissue that nourishes the early embryo and does not give rise to 
embryonic tissue but to the yolk sac. The term ‘definitive endoderm’ is given to the 
newly formed embryonic endoderm to differentiate it from the visceral endoderm. At the 
end of gastrulation (E7.5), the definitive endoderm consists of a single-cell thick layer of 
about 500 cells covering the bottom surface of the developing embryo (Wells and Melton, 
1999). By E8.5, the apparent 2-dimensional sheet folds and forms a gut tube with 
invaginations at the anterior and posterior ends of the tube to generate the foregut and 
hindgut respectively. The gut tube at this stage was divided into four physical regions 
based on a fate map generated by single endoderm cell labeling experiments at E7.5 
(Lawson et al., 1986). Region I, the ventral foregut, gives rise to the thyroid, lung, liver 
and ventral pancreas. Albumin, a characteristic marker of hepatic specification, can be 
detected at the ventral foregut at the stage E8.5 (Cascio and Zaret, 1991; Gualdi et al., 
1996). Regions II and III, the dorsal foregut and middle gut respectively, contribute to 
dorsal pancreas, stomach, duodenum, and part of intestine. Region IV, the hind gut, 
defines the large intestine and colon.   
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1.3.2 Liver morphogenesis 
Morphogenesis defines changes in cellular structures that lead to interactions between 
cells and tissues.  
Before the gut tube closes off by E9, invagination of the foregut physically presents itself 
juxtaposing the cardiac mesoderm. Triggered by inductive signals from the developing 
heart, the ventral foregut undergoes hepatic specification to become liver diverticulum 
(liver bud) at E8.5 (Douarin, 1975; Gualdi et al., 1996). Shortly after specification, the 
rapid proliferation of the hepatoblasts in the hepatic endoderm leads to the first 
morphologically distinguishable structure of liver, an outgrowth named the primary liver 
bud, appearing at the ventral floor of the foregut by E8.5 to E9.0. (Douarin, 1975; Gualdi 
et al., 1996). Cell linage tracing experiments showed that two distinct populations of 
endodermal cells, lateral and medial, arising from three spatially separated embryonic 
domains, converge to generate the epithelial cells of the liver bud (Tremblay and Zaret, 
2005). At this early stage the primary liver bud is surrounded by a basement membrane, 
which physically separates the bud from the surrounding septum transversum 
mesenchyme (STM) (Medlock and Haar, 1983). Following the progressive disruption of 
the basement membrane by E9.5, the pre-hepatic cells (hepatoblasts) delaminate from the 
young bud (foregut) and invade as cords into the surrounding STM. The hepatoblast 
cords mingle with the vitelline veins, anatomizing it into a venous bed and eventually a 
distinct liver organ by E10.5. At about E10, hematopoietic cells, which are responsible in 
establishing the vascular structure in the nascent liver, migrate from the yolk sac and 
aorta-gonad-mesonephros (AGM) region and become residents in the liver until birth 
(Johnson and Moore, 1975; Zaret, 1996; Muller et al., 1994; Medvinsky and Dzierzak, 
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1996). The fetal liver cells take gradual differentiation from hepatoblasts to hepatocytes 
and expand dramatically in volume.  
Continuous cell shape change is one of the key events during the course of 
morphogenesis that is believed to be crucial in cell movements. Soon after specification, 
the hepatoblasts change from columnar epithelia to pseudo-stratified epithelia, with 
concomitant "interkinetic nuclear migration" (INM) during cell division. This prepares 
the hepatoblasts ready for migration and differentiation in the next stage (Bort et al., 
2006). During the following differentiation period, the hepatoblasts/hepatocytes transit 
from an oblong shape at E12–14 to spherical around E18 and finally become polygonal 
just prior to birth (Vassy et al., 1988). At E13.5, hepatoblasts in the proximity to the 
portal mesenchyme will give rise to cholangiocytes (bile duct cells) (Shiojiri, 1984; 
Germain et al., 1988). The differentiated hepatocytes become functional by synthesis of 
secreted proteins and deposition of glycogen (Medlock and Haar, 1983) and the neonatal 
liver continues to develop and mature especially with regard to expression of metabolic 
enzymes. By E15, the liver is ready to perform its aforementioned tasks. 
 
1.3.3 Molecular mechanisms underlying liver development 
With their unique strengths in reverse genetics and tissue explantation assay, majority of 
the mature knowledge of the molecular mechanisms governing liver development is 
obtained from mouse and chick, with data dated as far back as more than 30 years ago. 
The findings so far can be summarized by a five-step model: (i) endoderm cells gaining 
competency to become hepatogenic cells, (ii) hepatoblast specification, (iii) liver bud 
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formation, (iv) liver bud expansion and (v) hepatocyte and cholangiocyte differentiation 
(Duncan, 2003). 
 
1.3.3.1 Acquisition of competency  
Liver organogenesis begins with the establishment of definitive hepatoblasts. Therefore, 
the first hepatogenic event is the specification of endodermal cells in the ventral foregut 
to become hepatoblasts. However, gene inactivation experiments showed that prior to the 
occurrence of hepatic specification, the expression of many genes in endoderm is 
necessary to enable the ventral foregut to respond to inductive signals. Such instinctive 
ability of the ventral foregut to take up hepatic cell fate is known as competency. Two 
groups of transcription factors, Foxas and Gatas, are characterized to be important for 














Figure 1-3 Hepatic competence and specification in the mouse liver 
(A) Acquisition of competence at 2-6 somite stage: The ventral foregut endoderm 
gains hepatic competence with the action of transcription factors Foxas and Gatas, 
and bone morphogenetic proteins (Bmps) that emanate from the adjacent cells of 
septum transversum mesenchyme (STM). (B) Hepatic specification at 7-8 somite 
stage: During hepatic specification, fibroblast growth factor (Fgf) signals from the 
cardiogenic mesoderm and Bmp signals from the STM, initiate liver gene expression 
in proximal endoderm, as well as block that for pancreas. Ventral endoderm cells are 
distal to the cardiogenic mesoderm and initiate the default pancreatic gene 
programme. Adapted from Zaret, 2002. 
 
Foxa (forkhead box A, also known as Hnf3, hepatocyte nuclear factor-3), a winged-helix 
transcription factor, was initially identified as a liver-enriched transcription factor which 
can bind to the promoters of the genes encoding α1-antitrypsin and transthyretin in 
mammals (Costa et al., 1989; Lai et al., 1990; Lai et al., 1991). They were also shown to 
regulate a variety of regulatory and metabolic proteins expressed in liver (Lee et al., 
2005a). All three Foxa member genes, Foxa1, Foxa2 and Foxa3 (formerly as Hnf3α, 
Hnf3β and Hnf3γ respectively) are expressed in the embryonic definitive endoderm and 
the adult liver. In terms of expression patterns, Foxa2 initially appears in the node at E6.5 
and is maintained throughout definitive endoderm, in the notochord, in ventral neural 
plate and subsequently in the floor plate during gastrulation at E7.5. The mRNA of Foxa1 
can be first detected at E7 in the late primitive streak and then takes similar pattern as 
Foxa2. Unlike Foxa1 and Foxa2, the expression of Foxa3 extends from hindgut to the 
foregut/ midgut boundary from E8.5 onwards (Lai et al., 1991; Ang et al., 1993; Kaestner 
et al., 1993; Monaghan et al., 1993; Altaba et al., 1993; Sasaki and Hogan, 1993). The 
embryonic liver histology is normal in Foxa1 or Foxa3 single gene knock-out mouse, 
however, the inactivation of Foxa2 leads to embryonic lethality shortly after gastrulation 
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due to the defective development of gut tube, node, notochord and floorplate (Ang and 
Rossant, 1994; Weinstein et al., 1994; Dufort et al., 1998; Kaestner et al., 1998; Kaestner 
et al., 1999; Shih et al., 1999). To circumvent that, a transgenic mouse with conditional 
Foxa2 knock-out (Foxa2Loxp/ Loxp; Foxa3-Cre) with specific abrogation of Foxa2 
restricted to endoderm but not notochord was generated. This mouse showed normal liver 
development (Lee et al., 2005a). The inactivation of single Foxa factor does not affect the 
hepatic development because of functional compensation by each other, however, a later 
double mutant Foxa1-/- ; Foxa2Loxp/ Loxp; Foxa3-Cre generated showed no liver bud. In 
addition, the endoderm from these double knockout mice could not acquire a hepatic fate, 
that is, they failed to initiate expression of the liver markers albumin and transthyretin 
even when they were cultured in vitro with exogenous inductive signal (Lee et al., 2005a). 
These findings suggested that Foxa1 and Foxa2 are required for ventral foregut to ‘sense’ 
the inductive signal at the onset of hepatogenesis, before it is capable to initiate hepatic 
specification.  
Another group of factors that is involved in the hepatic competency acquisition process 
of the foregut is Gata (GATA binding protein), belonging to the family of zinc finger 
transcription factors. Consistent expression patterns of Gata4 and Gata6 are found in the 
foregut around the time of hepatic specification (Arceci et al., 1993; Laverriere et al., 
1994; Morrisey et al., 1996; Suzuki et al., 1996; Gao et al., 1998; Koutsourakis et al., 
1999; Zhao et al., 2005). The gene knockout of Gata6 causes embryonic lethality before 
gastrulation and Gata4 mutant shows defects in foregut morphogenesis (Kuo et al., 1997; 
Molkentin et al., 1997; Narita et al., 1997; Morrisey et al., 1998; Koutsourakis et al., 
1999; Keijzer et al., 2001). The early development arrest in these mutants is believed to 
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be due to defects in the extraembryonic tissues. To circumvent this limitation, Zhao et al 
used a tetraploid embryo complementation strategy to generate viable null mouse 
embryos. In this elegant approach, Gata4-/- or Gata6-/- embryo nourished with wildtype 
extraembryonic endoderm tissue could survive till a later stage. They found that hepatic 
specification is normal in both chimeric embryos but the liver bud failed to expand, 
suggesting that although not needed for the specification step, these factors are essential 
for hepatoblast proliferation and differentiation (Zhao and Duncan, 2005; Watt et al., 
2007). Interestingly but not surprisingly, like Foxa1 and Foxa2, Gata4 and Gata6 may 
have redundant functions during hepatic specification. Double knockout of both factors is 
a probable way to obtain direct evidence of the indispensability of Gata factors in the 
establishment of hepatic competency in the endoderm.  
To investigate the mechanisms behind the gain of hepatic competency, the Zaret 
laboratory applied in vivo footprinting technique to analyze the albumin enhancer and 
found that strong binding sites for Foxas and Gatas are occupied in the foregut endoderm 
before initiation of albumin expression (Gualdi et al., 1996; Bossard and Zaret, 1998). 
They further demonstrated that from E8.5- E11.5, Foxa2 occupancy in the dorsal 
endoderm, usually giving rise to the intestine, conferred the dorsal endoderm the ability 
to express albumin when cultured alone in vitro, while the loss of Foxa2 occupancy at 
E13.5 led to the loss of albumin expression in the cultured dorsal endoderm (Bossard and 
Zaret, 2000). These data offered two possible explanations: the binding of Foxas and 
Gatas to the otherwise silent albumin enhancer will either facilitate the initiation of 
hepatic cell fate in the presence of the inductive signals in the ventral foregut, or remove 
repressive interaction in the dorsal endoderm. The functional implication of the 
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occupancy of Foxa2 and Gata4 on the albumin enhancer was being further explored by 
purified Foxa2 and Gata4, where they did not only recognize their target binding sites in 
highly condensed chromatin in a secondary factor independent manner. They also 
remodeled the chromatin structure exposing the local nucleosomes to generate a receptive 
status (Shim et al., 1998; Chaya et al., 2001; Cirillo and Zaret, 1999; Cirillo et al., 2002). 
Nevertheless, the occupancy by Foxa2 and Gata4 is necessary but insufficient to activate 
transcription of effector genes (Cirillo et al., 2002). Therefore the role for these 
transcription factors is that upon activation by inductive signals, they bind and remodel 
chromatin structure to initiate hepatic gene expression. 
 
1.3.3.2 Hepatic specification 
Upon acquisition of competence proper, the ventral foregut endoderm is capable to 
respond to mesodermal signals heading for hepatic cell fate (Figure 1-3B). This is 
consistent with the morphological patterning during this stage, where the invagination of 
the ventral foregut positions it intimately with the developing heart (Figure 1-3). The very 
first evidence of inductive mesodemal signals for hepatic specification came from 
LeDouarin’s classical tissue transplant studies in chick embryos (Douarin, 1975). She 
demonstrated that the close contact to cardiac mesenchyme is the prerequisite for the 
hepatic determination of endoderm of the foregut pocket at 5-6 somite stages 
(corresponding to about E8-8.5 in mouse). She further showed that pre-cardiac 
mesenchyme, when transplanted along with the pre-hepatic endoderm from earlier stage 
embryos, was the sole mesodermal tissue helping the endoderm to develop into a liver 
lobe (Douarin, 1975). These revolutionary results were recapitulated by work done in 
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mouse and quail embryos soon after (Houssaint, 1980; Fukuda-Taira, 1981). Molecular 
evidence supporting this arrived when Gualdi et al. precisely defined the stage of such 
cardiac mesoderm dependent hepatic specification as 7-8 somite stage (E8.5) in mouse 
using a sensitive method RT-PCR to detect albumin mRNA, a characteristic marker of 
hepatic cell linage (Gualdi et al., 1996). To pursue the signaling molecule(s) responsible 
for this process, Jung et al cultured ventral endoderm in isolation in vitro. They found 
that fibroblast growth factors (Fgfs) 1 or 2, but not 8 could substitute the cardiac 
mesoderm to induce the onset of hepatogenesis without the presence of pre-cardiac 
mesoderm (Jung et al., 1999).  
A twist in the field followed by when it turned out that Fgfs also guide cell fate choice in 
the ventral foregut: the posterior portion being close to the cardiac mesoderm, develops 
into the liver by inhibition of the default pancreatic cell fate by high concentration of Fgfs, 
while the anterior lip, being further away from the developing heart, gives rise to ventral 
pancreatic bud (Deutsch et al., 2001). This exclusion relationship between the liver and 
pancreas is also reflected by the commutative transdifferentiation between two cell fates 
in vitro and in vivo (Zaret, 2001; Li et al., 2005). 
The second inductive signal, bone morphogenetic proteins (Bmps) was discovered 
thankfully, from a transplantation experiment with contaminated septum transversum 
mesenchyme (STM). Rossi et al. found that the expression of hepatic genes in the co-
cultured explants of the cardiac mesoderm and ventral endoderm could be inhibited by 
addition of Noggin, a Bmp antagonist. Tissue contamination is highly possible due to the 
tight physical association between the pre-cardiac mesoderm and STM. Indeed, careful 
examination of the explants culture revealed the presence of Bmp4-producing STM. In 
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addition, adding Bmp4 or Bmp2 back into the explants culture could reverse the 
inhibition by Noggin and reinitiate the hepatic genes expression. The results suggested 
that Bmp signaling from the STM works in parallel with Fgf signaling from the cardiac 
mesoderm to initiate hepatogenesis in the ventral endoderm (Rossi et al., 2001).   
Apart from such promoting actions, one would expect certain counteract signals to 
balance up the system. Gualdi and colleagues found that hepatic genes expression in the 
co-cultured explants of ventral endoderm/cardiac mesoderm could be inhibited in 
presence of dorsal tissues. Similar inhibitory effect of dorsal tissues also was reflected by 
the fact that the dorsal endoderm lost the ability to express Albumin when cultured along 
with the dorsal mesoderm (Gualdi et al., 1996; Bossard and Zaret, 2000). However, the 
nature of this inhibition has yet to be discovered.  
In addition to the mouse and avian system, recent genetic work conducted in a new model 
system, the zebrafish revealed that prt, a previously unidentified Wnt2b homologue from 
the nearby bilateral mesoderm, positively regulate liver specification (Ober et al., 2006). 
This will be discussed further in later section.  
Thus, the combination of local transcription factors and morphogenic molecules from 
adjacent tissues constitutes hepatic specification: Foxa and Gata factors impart the ventral 
and dorsal endoderm competency to follow hepatic cell fate. This is followed by a series 
of morphogenesis movement that presents the ventral foregut in close proximity to the 
developing heart. The ventral foregut responds to the inductive signals released from 
neighboring cardiac mesoderm and septum transversum mesenchyme to be specified into 
hepatoblast, while the dorsal endoderm, being inhibited by the surrounding dorsal 
mesoderm, does not undergo hepatogenic events (Figure 1-3).  
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1.3.3.3 Liver bud formation and growth 
After specification, hepatoblasts undergo rapid proliferation and differentiation under the 
continued combined actions of many intrinsic transcriptional factors and complex 
interactions with other tissues. There are two separable growth phases during the growth 
of the liver bud: (i) physical invasion of the proliferating hepatoblasts into the STM to 
form a distinct liver organ by E9.5 and (ii) further proliferation of the hepatoblasts to 
increase liver size and differentiation to become hepatocytes and bile duct cells. 
 
1.3.3.3.1 Liver bud formation 
Being a highly vascularized organ, endothelial cells surrounding the early liver bud play 
an important role during the outgrowth of liver bud. As early as E8.5, shortly after 
hepatic specification, endothelial cells are found to define the nascent specified 
hepatoblasts from the surrounding septum transversum mesenchyme (STM) (Matsumoto 
et al., 2001). A knockout of Flk1, a gene encoding vascular endothelial growth factor 
receptor 2 (Vegfr2), resulted in the failure of the formation of endothelial cells and blood 
vessels (Shalaby et al., 1995). It was found that the formation of liver bud in Flk1-/- 
embryo is blocked after the hepatic specification, indicating that endothelial cells are 
crucial for the early liver bud formation prior to vascular function. However, the 
signaling molecule(s) behind this phenomenon await elucidation (Matsumoto et al., 2001).  
Besides the essential functions in hepatic specification, Fgf and Bmp signals also exert 
effect on liver bud formation. Fgf8 secreted by the cardiac mesoderm is necessary for the 
morphogenetic outgrowth of the hepatic endoderm and the PI3 kinase/AKT pathway 
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activated by Fgf signaling contribute to liver bud growth (Jung et al., 1999; Calmont et al., 
2006). Bmps from STM are also essential for liver bud growth (Rossi et al., 2001). 
Similar to hepatic specification, liver bud formation also requires a number of crucial 
transcription factors in addition to morphogenic signaling molecules. The gene Hex (also 
known as Hhex, haematopoietically expressed homeobox) encodes a divergent homeobox 
transcription factor. The transcripts of Hex appear in the ventral endoderm at E8.0, early 
before the hepatic specification, and is maintained in the liver bud (Thomas et al., 1998; 
Bogue et al., 2000). The Hex knockout mouse is defective in the formation of liver and 
thyroid bud (Keng et al., 2000; Martinez Barbera et al., 2000). Hepatic program initiation 
by the endoderm in the Hex-/- embryo was evident by the visualization of a hepatoblast of 
characteristic columnar shape and the expression of liver specific genes (e.g Albumin) 
before E9.5 (Martinez Barbera et al., 2000; Bort et al., 2004). However the Hex-/- 
hepatoblasts display a reduced proliferative rate and fail to invade STM to form a liver 
bud (Bort et al., 2004). Further investigation showed that the failure of liver budding in 
Hex-/- embryo is due to the disruption of Hex-dependent cell morphological change from 
columnar epithelia to pseudostratified epithelia which is necessary for hepatoblasts to 
undergo migration and differentiation. The failure of morphological change in Hex-/- 
embryo was later demonstrated as a result of the inhibition of interkinetic nuclear 
migration (INM) by the ectopic activation of sonic hedgehog signaling (Bort et al., 2006). 
The phenotypes exhibited by Hex-/- embryos is the earliest perturbation to hepatogenesis 
described so far (Duncan, 2003). Another transcription factor involved in liver bud 
formation is Prox1 (prospero-related homeobox 1), a homeobox transcriptional factor 
homologous to Prospero in Drosophila (Oliver et al., 1993). At embryonic day 9.0-9.5 (E 
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9.0-9.5), Prox1 expression in mouse embryo is localized in the hepatic primordium and 
dorsal pancreatic bud. At E 10-10.5, Prox1 expression is detected in the liver bud, gall 
bladder, and dorsal and ventral primordial (Sosa-Pineda et al., 2000). 
Immunofluorescence experiments with anti–β-galactosidase, anti-albumin and anti-
fetoprotein antibodies revealed that the Prox1-expression cells are hepatocytes (Sosa-
Pineda et al., 2000). Although having no difficulties in forming distinct liver lobes, the 
Prox1-/- hepatoblasts failed to delaminate from the foregut to migrate into the septum 
transversum mesenchyme and clustered within a core. Upon closer examination, 
hepatoblasts were indeed absent from the developing liver lobes (Sosa-Pineda et al., 
2000). This was later found to be a consequence of the inability to degrade the laminin 
and type IV collagen rich basement membrane and extra deposition of E-cadherin in the 
surrounding extracellular matrix (ECM) (Sosa-Pineda et al., 2000). In combination, these 
data demonstrated that although Prox1 may be dispensable for hepatic specification, it is 
required for hepatoblast migration and the morphogenic expansion of the primary liver 
bud (Sosa-Pineda et al., 2000). 
Beside the essential functions of Gata factors (Figure 1-3A) in the acquisition of the 
competency, both Gata4 and Gata6 are also indispensable for the formation of the liver 
bud as demonstrated by the rescue of Gata4-/- and Gata6-/- embryos by wildtype 
extraembryonic endoderm (Zhao and Duncan, 2005; Watt et al., 2007) 
 
1.3.3.3.2 Growth and apoptosis of hepatoblasts 
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After the initialization of a physical liver primodium, the next step is the proliferation and 
differentiation activities of the hepatoblasts within the liver bud. These are regulated by 
diverse paracrine stimuli and intrinsic factors (Figure 1-4A).  
 
Initiation of the liver bud The liver bud formation
BA
 
Figure 1-4 Liver bud formation during mouse liver development  
(A) Initiation of liver bud at 11-13 somite stage: Hepatoblasts become columnar in shape 
after hepatic specification. These transitions seem to be elicited by signals that specify the 
endoderm. Signaling molecules including Bmp and Hgf from septum transversum 
mesenchyme (STM) and Vegfr2 from primitive endothelial cells, and transcription 
factors (such as Hex, Prox1, Hlx and c-Met) are essential to promote the initiation of liver 






morphogenesis is marked by the formation of the rostral diverticulum of the gut, 
remodelling of the extracellular matrix around the hepatoblasts and E-cadherin-based 
connections between the cells, and the proliferation and migration of hepatoblasts into the 
surrounding STM (light orange). During this stage primitive endothelial cells develop into 
blood vessels (not shown) and haematopoietic cells migrate into the liver bud and stay as 
residents until birth. Bmp, bone morphogenetic protein; c-Met, HGF receptor; Hgf, 
hepatocyte growth factor; Vegfr2, vascular endothelial growth factor receptor 2. Adapted 
from Zaret, 2002. 
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While describing the requirement of inductive mesodemal signals for hepatic 
specification by classical tissue transplant studies in chick embryos, the same article was 
the first one that reported on the existence of a second, additional stimulation from the 
lateral plate mesoderm derived mesenchyme needed to support the grafted endoderm to 
develop into a liver lobe (Douarin, 1975). However, Duncan believed that the STM- 
derived ECM was the corresponding tissue (Duncan, 2003). The ECM directs the liver 
development in two ways: either by concentrating signaling molecules or by mediating 
intracellular signal through interaction with integrins. β1-integrin is a component of the 
receptor for ECM proteins laminins and collagens. The β1-integrin knockout embryonic 
stem cells fail to colonize the liver, indicating the importance of ECM for liver 
development (Fassler and Meyer, 1995). The other evidence supporting the role of 
integrins in liver development was provided by Smad2+/- Smad3+/- (two Tgf-β signal 
transducers) mouse embryos where the loss of β1-integrin expression leads to liver 
hypoplasia (underdevelopment) (Weinstein et al., 2001). Similar to Smad2+/- Smad3+/- 
mouse, the mouse lacking either hepatocyte growth factor (Hgf), expressed in STM and 
hepatocytes, or Hgf receptor c-Met, expressed in hepatocytes, also suffers from severe 
liver hypoplasia (Bladt et al., 1995; Schmidt et al., 1995; Uehara et al., 1995). The 
successful rescue of liver growth and β1-integrin expression of the Smad2+/- Smad3+/- 
liver explants in vitro indicated that Hgf and Tgf-β converge on the regulation of β1-
integrin to control hepatoblasts growth (Weinstein et al., 2001). Hlx (H2.0-like 
homeobox gene) and N-myc are among the STM-producing factors which control 
hepatogenesis (Figure 1-4A). Inactivation of Hlx does not affect the initiation of hepatic 
program but the mutant liver fails to expand and is only a small bud at E14.5 without 
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apoptosis (Hentsch et al., 1996), while hepatoblasts in N-myc knock-out mouse undergo 
extensive apoptosis (Giroux and Charron, 1998), implying that Hlx and N-myc promote 
hepatoblasts growth and survival, probably by regulation the expression of growth factors 
and survival factors respectively.  
Besides STM, blood cells residing in the fetal liver are also the source of regulators for 
hepatogenesis. Jumonji, an AT-rich domain transcription factor, is highly enriched in 
megakaryocytes found in the liver at mid-gestation (Motoyama et al., 1997). The 
hepatocyte number in Jmj-/- mouse is markedly reduced and differentiation of 
hepatocytes is compromised in the primary culture (Anzai et al., 2003), suggesting that 
Jumonji probably regulates the production of paracrine growth factors to promote 
hepatoblasts proliferation in mid-gestation and help hepatocytes differentiate in late-
gestation through the action of increased expression level in hepatocytes. Other less 
characterized factors include Foxm1b and Xbp1. Foxm1b is an intrinsic transcription 
factor to promote hepatocytes proliferation by regulating mitosis in the fetal liver and 
regenerative liver (Ye et al., 1997; Krupczak-Hollis et al., 2004), while the inactivation of 
Xbp1 (X-box binding protein 1), which is expressed in the developing liver, causes 
reduced growth and prominent apoptosis in hepatoblasts (Reimold et al., 2000).  
To achieve population equilibrium in the final functional liver, it is logical that 
hepatoblasts receive various necrotic and apoptotic signals in addition to the 
aforementioned growth signals. Pik3r1 encodes three components of Phosphoinositide-3- 
kinase (Pik3s) and the mouse lacking Pik3r1 gene dies prenatally and shows extensive 
hepatocyte necrosis (Fruman et al., 2000). Two signaling pathways are necessary to 
protect the hepatoblasts from tumor necrosis factor (TNF) -induced apoptosis: NFκB 
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(nuclear factor κB) pathway and SAPK/JNK (the stress-activated protein kinase/ c-Jun N-
terminal kinase). Mice lacking either one of Rel-A, IKK-β and IKK-γ (NEMO), 
components of the NF-kB signal pathway, suffer from extensive apoptosis of hepatocytes 
in the mid-fetal liver (Beg et al., 1995; Li et al., 1999; Tanaka et al., 1999; Rudolph et al., 
2000). c-Jun knockout mice die between E11.5 and E15.5 and exhibit defective liver dev 
elopment (Hilberg et al., 1993; Johnson et al., 1993). This mouse also exhibits 
hypoplastic liver with features of apoptosis，similar phenotypes are also displayed in the 
knockout of the mediator of SPAK pathway, Sek1 (MKK4, mitogen-activated kinase 
kinase 4) (Hilberg et al., 1993; Johnson et al., 1993; Ganiatsas et al., 1998; Nishina et al., 
1999). These results suggested that these genes are crucial for the survival of hepatocytes. 
Finally, the Wnt/ β-Catenin pathway also seems to be involved in  liver development by 
noticing abundant gene expression in the fetal liver during E10-12 (Micsenyi et al., 2004). 
Moreover, ectopic activation of β-Catenin causes hyperproliferation of hepatocytes and 
clinically, constitutively active β-Catenin mutations are found in about 70% of human 
hepatoblastoma (Koch et al., 1999; Wei et al., 2000). 
 
1.3.3.4 Hepatocyte differentiation and establishment of hepatic architecture 
The two major processes taking place in the newly formed liver bud is rapid proliferation 
of hepatoblasts, followed by gradual maturation and differentiation. Only upon 
completion of the terminal phase of differentiation, hepatoblasts become functional 
polarized hepatocytes, performing metabolic and other diverse functions in the late 
gestation period and soon after birth. Concurrently, physically complex architecture is 
achieved by organization of parenchymal and mesenchymal tissues. During this process, 
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cytokines secreted by blood cells and endothelial cells play essential roles. Oncostatin M 
(OSM), an Interleukin-6 family cytokine, is secreted by the resident haematopoietic cells 
after the blood vessel is formed in the liver. It operates via the promotion of the 
differentiation of hepatocytes through the gp130 signal transducer (Kamiya et al., 1999). 
OSM induced terminal differentiation is facilitated by Engelbreth-Holm-Swarm sarcoma 
(EHS)-derived ECM, indicating that ECM is important to hepatocytes maturation as well 
(Kamiya et al., 2002). 
The transcriptional factors that regulate hepatocyte differentiation include c/EBPα 
(CCAAT/ enhancer binding protein α), Foxas, Hnf1α and Hnf4α (hepatocyte nuclear 
factor). Homozygous inactivation of c/EBPα, Foxa1 or Foxa3 does not affect early 
development of liver but energy homeostasis within the young organ is impaired. Similar 
phenotype is observed in conditional knockout of Foxa2 in the endoderm or hepatocyte 
(Friedman and Kaestner, 2006). The products of some metabolic enzymes and hepatic 
proteins are lost or diminished in Hnf1α-/-, albeit  apparent normal liver development in 
general (Pontoglio et al., 1996).  
Studies using rat fibroblast hybrid cell lines and somatic hepatica cells variants that 
possess de-differentiation properties suggested that Hnf4α acts as an important regulator 
of hepatocyte differentiation (Bulla, 1997; Bulla and Fournier, 1994). Knockout mutants 
of Hnf4α die during gastrulation due to defects in the visceral endoderm (Chen et al., 
1994; Duncan et al., 1997). Tetraploid embryo complementation revealed that, rescued 
Hnf4α-/- embryos exhibit impaired hepatocyte differentiation with morphologically and 
histologically normal liver (Li et al., 2000). The other consistent phenotype in this mutant 
is that in all Hnf4α-null fetal livers examined, the expression of a large array of genes 
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associated with mature hepatocyte function was virtually abolished (Li et al., 2000). 
Among these down-regulated genes, apart from numerous hepatic proteins and enzymes, 
the expression levels of Hnf1α and orphan receptor Pxr (pregnane-X-receptor, also 
known as Nrli2; nuclear-receptor subfamily 1, group I, member 2) are also diminished, 
suggesting that Hnf4α probably regulates their transcription (Li et al., 2000). The results 
from mouse with postnatal inactivation of Hnf4α in hepatocytes confirm the central roles 
of Hnf4α on the regulation of metabolic enzymes production (Hayhurst et al., 2001). 
Further supporting evidence poured in when α-fetoprotein enhancer and albumin 
promoter driven Cre recombinase directed Hnf4α conditional deletion results in 
hypoglycemia and failure of expression of genes associated with hepatocyte activities. 
Disruption of the formation of bile canaliculi, a consequence of the failure of hepatocyte 
expression of cell junction molecules, is also found in E18.5 mutant mouse, indicating 
that Hnf4α is necessary for the differentiation of hepatocyte and the establishment of 
hepatic architecture (Parviz et al., 2003). Using chromatin immunoprecipitation and 
promoter microarrays, Odom et al. revealed that Hnf4α binds to the promoter of  about as 
many as 40%  liver genes (1575 genes) while Hnf1α and Hnf6 occupy overwhelming 222 
and 227 promoters of genes respectively. Furthermore, most Hnf1α and Hnf6 bound 
promoters are also occupied by Hnf4α. Apart from having demonstrated the central role 
of Hnf4α in defining a fully differentiated hepatocyte phenotype, the genomic data has 
also revealed the complex underlying Hnfs network governing this late stage of liver 
development (Odom et al., 2004).  
 
 29
1.3.3.5 Cholangiocyte differentiation 
The main function of the bile duct system is to drain bile from the liver. By combining 
with the duct from the gallbladder to form the common bile duct, it channels the bile 
from the liver into the small intestine when food is being digested. The development of 
the bile duct system is considered to be part of liver organogenesis because a physical 
partition of the ductal system runs within the liver. Intrahepatic bile ducts (IHBD) define 
ducts that function inside the liver while extrahepatic bile ducts (EHBD) encompass ducts 
that operate outside the liver. The lumen of IHBD and EHBD is lined by biliary epithelial 
cells (BEC). Though cell lineage tracing evidence is lacking, the BEC are believed to be 
derived from bipotential hepatoblasts having the ability to differentiate into either 
hepatocytes or BEC (Lemaigre, 2003).  
The development of IHBD can be divided into two phases: cholangiocytes (immature, 
unspecialized BEC) induction and bile duct morphogenesis. Upon the onset of 
cholangiocyte differentiation, expression of biliary- specific cytokeratins in a subset of 
hepatoblasts around the portal mesenchyme expressing is initiated at E13.5. These 
hepatoblasts, named biliary precursor cells, transiently express albumin and α-fetoprotein, 
characteristic markers of hepatoblasts and hepatocytes. Other hepatoblasts express much 
less biliary- specific cytokeratins (Shiojiri, 1984; Shiojiri and Katayama, 1987; Germain 
et al., 1988; Shiojiri et al., 1991). At E15.5, biliary precursor cells form a single cell layer 
called the ductal plate and the cell layer duplicates at E16.5, forming a dual layer 
structure. Around E17.5 the bilayer ductal plates remodel into bile ducts and incorporate 
into the portal mesenchyme before birth (Clotman et al., 2002; Lemaigre, 2003; Fitz, 
2002). 
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Cell-matrix and cell-cell interactions are suspected to regulate the development of biliary 
tracts because of the expression of proteins essential for interactions in BEC (Lemaigre, 
2003). Since biliary precursor cells originate from the proximity of the portal 
mesenchyme, mesenchyme is likely involved in cholangiocyte differentiation. This 
hypothesis is confirmed by the abnormal gallbladder development in Foxf1+/- mouse. 
Foxf1 is a transcription factor expressed in STM. In Foxf1+/- mouse, haploinsufficiency 
only appears in the formation of gallbladder while the IHBD is normal (Kalinichenko et 
al., 2002). Another example is Hgf, which is also expressed in STM. Hgf is able to 
promote the differentiation of albumin-negative hepatic cells into albumin-positive 
bipotent hepatoblasts in vitro, probably via induction of the expression of c/Ebpα (Suzuki 
et al., 2002; Suzuki et al., 2003). The possible roles of transcription factors Hnf6 and 
Onecut2 (Oc2), both expressed in BEC, in cholongiocyte differentiation have been 
explored. Hnf6 is expressed in the early liver, the hepatic bile ducts and the gall bladder 
(Landry et al., 1997; Rausa et al., 1997). In homozygous Hnf6-null mutants, the gall 
bladder is absent and the hepatic bile ducts are not well refined (Clotman et al., 2002). 
Most importantly, at E 13.5 there seem to be more cells that express early biliary markers, 
which indicate excess biliary commitment from hepatoblasts. In addition, in contrast to 
the limited distribution pattern of biliary precursor cells proximal to the portal vein in 
control embyos, biliary cytokeratins expressing hepatoblast clusters are found throughout 
liver parenchyma in Hnf6-/-; Oc2-/- mouse. Another consistent phenotype is that the 
development of EHBD is disrupted in Hnf6-/- mouse (Clotman et al., 2002; Clotman et al., 
2005). Therefore it is believed that these two factors work in a cooperative manner to 
restrict the extent of biliary-cell commitment from haptoblasts. Clotman et al. further 
 31
elucidated that Hnf6 and Oc2 inhibited Activin/Tgfβ signaling in the parenchyma to 
promote hepatocyte differentiation, by allowing high Activin/Tgfβ signaling around the 
portal vein to facilitate BEC differentiation (Clotman et al., 2005). The involvement of 
Tgfβ signaling is confirmed by the fact that Smad2+/-Smad3+/- mouse is defective in the 
IHBD development (Weinstein et al., 2001).  
The expression of Hnf6 is under the coordinated control of many factors (Suzuki et al., 
2003). As a transcription factor, Hnf6 also regulates the expression of another 
transcription factor Hnf1β (also known as vHnf1) directly (Clotman et al., 2002; 
Coffinier et al., 2002). Hnf1β is expressed in the epithelia in the liver, pancreas and 
kidney. Conditional knockout of Hnf1β in hepatoblasts causes BEC to form transient 
biliary cysts due to abnormal tubulogenesis (Coffinier et al., 2002). Both BEC and renal 
epithelia have primary cilia at the apical surface, thus the anomalies of BEC in Hnf1β-/- 
are referred to the defects in cilia formation regulated by Hnf1β. The mutations 
corresponding for Meckel syndrome, an autosomal-recessive disease with renal cysts 
polydactyly and ductal plate malformations, are found in the genes coding proteins 
associated with primary cilia, further demonstrating normal primary cilia development is 
necessary to cholangiocyte differentiation (Clotman et al., 2008). 
In addition to its function in hepatoblast proliferation discussed previously (section 
1.3.3.3.2), Foxm1 is also crucial to promote bipotential hepatoblasts to take biliary cell 
fate. Foxm1-/- hepatoblasts fail to express biliary cytokeratins and nuclear level of Hnf1β, 
resulting in vacancy of IHBD in the liver (Krupczak-Hollis et al., 2004). Expression of 
Hex, being a early factor in liver bud formation, is also detected in IHBD and EHBD 
during later development (Keng et al., 1998; Thomas et al., 1998; Bogue et al., 2000). 
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Endodermal deletion of Hex guided by Foxa3-Cre results in a small cystic liver and total 
loss of EHBD structure and Hnf4α and Hnf6 expression; while the liver-specific deletion 
facilitated by Alfp-Cre cause abnormal development of IHBD and failure of Hnf1β 
expression in many BEC (Hunter et al., 2007). Interestingly but maybe not surprisingly, 
hepatic artery development is tightly associated with IHBD morphogenesis, as suggested 
by the failure of arterial branches formation in the liver of Hnf6 or Hnf1β knockout 
mouse (Coffinier et al., 2002; Clotman et al., 2003). 
One established biliary tract disease is Alagille syndrome (AGS), an autosomal dominant 
disease with developmental defects in several organs, paucity of IHBD and cholestasis 
(blockage of the flow of bile from the liver) (Lemaigre, 2003). A ligand of Notch, 
Jagged1, is the corresponding gene and is expressed in the developing BEC in human (Li 
et al., 1997; Oda et al., 1997). Unlike in human, the expression of Jagged1 in mouse is 
detected in hepatic arteries and portal vein instead of BEC. Haploinsufficiency does not 
exist in mice, either. However surprisingly, Jagged1+/-Notch2+/- and Notch2-/- mice 
display AGS-like phenotypes (McCright et al., 2001; McCright et al., 2002). Hes1, a 
basic helix-loop-helix transcription factor, is a mediator of Notch signaling pathway and 
expressed in BEC (Kageyama and Ohtsuka, 1999; Kodama et al., 2004). Studies in the 
Hes1 knockout mouse revealed two functional aspects of Hes1 with relevance to biliary 
development: the inhibition of the potential pancreatic cell fate in EHBD (Sumazaki et al., 
2004) and the regulation of tubulogenesis in IHBD (Kodama et al., 2004).  
To this point, the structure, functions and developmental stages of the liver have been 
discussed quite extensively based mainly on the data laid down by the mouse model. 
Combining its mammalian properties (which make it most relevant to human) and 
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powerful manipulating tools (such as cell culture, explants culture, transplantation and 
genes knock-in/-out technologies), the mouse has naturally dominated the field for the 
past 30 years yielding important progresses. Nonetheless, one big experimental limitation 
of this animal is the feasibility to identify novel factors via large-scale, unbiased genetic 
screenings. The next section of this chapter introduces a vertebrate, the zebrafish, as an 
emerging model for the study of liver development.  
 
1.4 Zebrafish: A model for studies of liver development 
1.4.1 Advantages of zebrafish 
Life science these days encompasses a wide range of scientific disciplines including 
developmental biology, cell biology, biochemistry, genetics, molecular biology, 
genomics, to name a few. One of the criteria conferring an organism the ideal model 
system for life science research is its feasibility across as many of these disciplines as 
possible. Zebrafish possesses obvious advantages that make it suitable for developmental 
and genetic investigations. The following characteristics support zebrafish as an excellent 
model organism for developmental study: unlike intrauterine embryogenesis of mouse, 
the fertilization and development of zebrafish embryos happen externally. This, in 
combination with the translucent nature of the embryos, enables easy access to the 
developing embryos for experimental manipulation and subsequent visual observations. 
In addition, these two features also permit valuable real-time observation of 
embryogenesis, offering excellent spatial and temporal resolutions on developmental 
processes. One practical factor is the fast development program that facilitates 
examination of embryogenesis within days instead of weeks as in the mouse system. 
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Additionally, zebrafish embryos can receive enough oxygen through diffusion to support 
embryonic development to a relatively late stage, which circumvents the undesirable 
hindrance of early embryo lethality encountered in mammalian genetic models, where the 
mutants are unviable due to lack of circulation (Stainier, 2001).  
Besides such characteristic advantages on developmental investigation, zebrafish also 
offers excellent feasibility on genetic manipulations. It is liable to various methodologies 
developed for both forward and reverse genetics. The most important benefit of zebrafish 
that has been instrumental in the field is its feasibility to carry out large-scale forward 
genetic screenings owing to its high fecundity (100-200 embryos weekly per female), 
short generation time (3 months for maturation) and low breeding and maintenance cost 
(Westerfield, 1989). Prior to the introduction of this organism, any possibility of a large-
scale forward genetic screen was ruled out in vertebrate animals due to prohibitively 
expensive cost and intrauterine embryogenesis (mouse). Therefore, as mentioned earlier, 
most genetic data in mouse was limited to reverse genetic approach which heavily 
depends on previous knowledge from biochemical experiments and homologues mutants 
in invertebrates such as Caenorhabditis elegans and Drosophila melanogaster. One 
obvious drawback of this is the unavailability of such prior data due to various reasons 
for example, an unexplored area. On the other hand, conducting a phenotype-based 
forward genetic screen for specific gene knockout mutants would offer an unbiased 
strategy to approach a specific biological question of interest. Most importantly, forward 
genetic screen has the potential in the identification of novel genes that cannot be so 
straightforwardly achieved by reverse genetics methods. 
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Several kinds of mutagens have been used successfully for mutagenesis for forward 
genetic screens in zebrafish. By employing ENU (N-ethyl-N-nitrosourea), a point 
mutation mutagen (Mullins et al., 1994; Solnica-Krezel et al., 1994), two successful 
large-scale screens have been carried out: one done iat the Max Planck Institute in 
Tubingen, Germany (Haffter et al., 1996) and the other one, at Massachusetts General 
Hospital, Boston, USA (Driever et al., 1996). Together, these two revolutionary screens 
have harvested about 1740 mutants, covering 400-600 different loci, with visible 
morphological defects in all aspects of embryogenesis (Amsterdam and Hopkins, 2006). 
Motivated by these two successful pioneering efforts, zebrafish continues to be exploited 
by the community to isolate mutants impaired in a whole range of specific defects, such 
as behavior and physiology (Granato et al., 1996; Alexander et al., 1998; Farber et al., 
2001; Patton and Zon, 2001; Trede et al., 2001; Shepard et al., 2005).  
ENU-induced mutations can be identified by either positional cloning or candidate genes 
approach (Schulte-Merker et al., 1994; Talbot et al., 1995; Talbot and Schier, 1999; 
Bahary et al., 2004). One of the first taste of success of this initiative is reflected by the 
isolation and characterization of novel genes in the development of heart, blood, neuron 
and other organs, which also reveals conserved molecular mechanisms of development 
among vertebrates (Dooley and Zon, 2000). Gene cloning is greatly facilitated by the 
initiation of zebrafish genome sequencing project in early 2001 by the Sanger institute 
((http://www.sanger.ac.uk/Projects/D_rerio/)). The first draft of complete genome 
sequence is expected to be released early next year.  A comprehensive 
website, http://zfin.org, has also been set up and dedicated to the zebrafish community for 
information and resource sharing and exchange.  
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Using a mutagen that operates in a totally different basis, the Hopkins’ laboratory 
successfully achieved about 520 mutants representing almost 400 different genes 
essential for early development in zebrafish (Amsterdam et al., 1999; Golling et al., 2002; 
Amsterdam and Hopkins, 2004). By randomly integrating a murine leukemia virus (MLV) 
based pseudo-typed retrovirus into the zebrfish genome to achieve gene inactivation, 
Hopkin et al. is able to easily isolate the defective genes efficiently by carrying PCR 
across the known proviral tagged sequence. 
Boasting with the two distinct advantages of sufficiently high integration rate and ease of 
gene cloning, the commercial potential of this tactic has attracted Znomics Inc. to attempt 
saturation mutagenesis to establish a permanent library of cryopreserved sperms 
harboring proviral insertions with at least one insertion in each zebrafish gene. Similar to 
the protocol reported by Wang et al, each sperm sample collected from mutants was 
divided into two portions, one for cryopreservation, and the other one for preparation of 
genomic DNA to identify the mutated genes in the corresponding sample in library. The 
particular cryopreserved sperm can be revived for population generation upon identifying 
the mutated gene of interest  (Amsterdam and Hopkins, 2006; Wang et al., 2007). 
However, regardless of its marked advantage, the type of mutant alleles generated by 
retroviral insertions is limited to mostly hypomorph (partial loss of function) or amorph 
(null) (Amsterdam and Hopkins, 2006). On the other hand, chemincal mutagenesis like 
ENU has the potential to generate other flavors of alleles such as antimorph 
(opposing/dominant negative function), hypermorph (exaggerated function) and 
neomorph (gain of function), in addition to those hypomorph (partial loss of function) 
and amphorph (null) created by insertions.  
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Reverse genetic tools have also been successfully used in zebrafish. By large-scale 
sequencing, TILLING (targeting- induced local lesion in genes) enables the identification 
of targeted mutant/gene with high resolution to the exact nucleotide (hence defining the 
type of alleles of interest) (Wienholds et al., 2002; Wienholds et al., 2003; Stemple, 
2004). Using this method, mutants carrying defects in many genes of interest with prior 
reports in mouse or other model organisms have been isolated. Morphlino (chemically 
modified antisense oligonucleotides) is a widely used tool to knockdown target gene by 
blocking protein translation or mRNA splicing (Summerton and Weller, 1997; 
Nasevicius and Ekker, 2000; Heasman, 2002). Microinjection of target morphlino at one 
cell stage has been routinely employed in the field to knock down target gene in zebrafish 
embryo. Besides these regular genetic manipulations, a number of other technologies are 
also developed in zebrafish to facilitate functional studies.  
Foreign DNA fragments were found to be able to transmit to germ-line to generate 
transgenic animals when injected into the cytoplasm of one-cell embryos (Stuart et al., 
1988; Culp et al., 1991). Using this technology, numerous transgenic fish lines with gene-
specific promoter driven reporter gene, such as green fluorescent protein (GFP) or red 
fluorescent protein (RFP) have been generated. A relevant example is a line with the 
whole gut tube and associated organs labeled with GFP (Field et al., 2003b). The value of 
this line has been extensively reflected in forward genetic screens and cell lineage tracing 
experiments. Based on similar working principles as the pseudo-typed retrovirus used in 
insertional mutagenesis, two transposons, Tol2 and Sleeping Beauty (SB), are capable to 
transmit into germ-line as well albeit at a lower efficiency. Apart from gene trapping, this 
system has been attempted on enhancer trapping as well (Davidson et al., 2003; 
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Kawakami et al., 2004). Conditional systems have been invaluable in performing specific 
spatial and temporal labeling and overcoming embryonic lethality. Two widely used 
inducible systems, tetracycline (Tet)-On system and Cre/loxP recombination system, 
have been adopted successfully in zebrafish recently to achieve specific labeling on the 
gene of interest at the desired stage (Huang et al., 2001; Pan et al., 2005). The heat shock-
inducible gene expression system has also been set up and applied in zebrafish (Pyati et 
al., 2005; Pyati et al., 2006).  
The unique combination of the feasibility of genetic manipulation and highly conserved 
molecular mechanisms among vertebrates has projected zebrafish to be a potential human 
disease model (Zon, 1999; Patton and Zon, 2001; Amsterdam and Hopkins, 2006). In fact, 
this anticipation has recently been extended to exploiting this organism for high 
throughput chemical and drug screen (Zon and Peterson, 2005; Murphey and Zon, 2006). 
With the availability of such extent of favorable inherent characteristics, manipulation 
tools and scientific support, zebrafish is currently enjoying all the attention that it 
undeniably deserves.  
Most importantly with relevance to this thesis, zebrafish is especially amenable for the 
investigation of liver development for one unique property, in addition to the general 
advantages for developmental and genetic study. Genetic analysis of liver in mouse is 
notoriously hurdled by early lethality in liver mutants due to anemia, for liver being an 
early hematopoietic organ in mammals (Reimold et al., 2000). In contrast, hematopoiesis 
in zebrafish takes place in the intermediate cell mass (ICM) and subsequently in the 
kidney, instead of the liver (Thisse and Zon, 2002). Liver defects do not lead to anemia, 
extending the lifespan of liver mutants to a relatively late stage for analysis.  
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1.4.2 Liver development study in zebrafish 
Study of liver development in zebrafish has a relatively short history. Currently the 
morphology of zebrafish liver organogenesis has been well described, especially in a 
instrumental study by Field et al. with the help of the Tg (gutGFP) S584 transgenic fish 
(Figure 1-5) (Field et al., 2003b). In addition, a few zebrafish genes related to liver 
development have been identified in genetic screenings. The initiation of liver 
development study in zebrafish has greatly attributed to the 2 major mutant screens 
mentioned earlier (section 1.4.1). Although historically dominated by reports generated in 
mouse, valuable zebrafish data accumulated over the past few years is beginning to reveal 
invaluable new insights into this field. Similar to mouse, the different phases of liver 
development in zebrafish can be discussed in 3 aspects: morphological description, 
developmental stages (early bud formation, proliferation and differentiation) and roles of 
signaling molecules and molecular factors in each stage. 
 
1.4.2.1 Morphological description of liver development  
In zebrafish, the endoderm is derived from the bipotential mesendodermal cells at mid-
blastula stages, restricted to four-cell tiers close to the margin of the blastula (Kimmel et 
al., 1990; Warga and Nusslein-Volhard, 1999). After undergoing a series of 
morphogenetic processes, endodermal cells assemble to form a medial solid rod by 18 to 
20 hour post fertilization (hpf) (Warga and Nusslein-Volhard, 1999; Ober et al., 2003). A 
gut GFP transgenic line, Tg(gutGFP)S584 has gfp gene specifically expressed in all 
digestive organs, reveals two phases of liver morphogenesis: budding and growth (Field 
et al., 2003b). Based solely on morphological observations, the budding process is further 
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divided into three stages: stage I is a period of acquiring thickness of two regions on the 
endoderm rod at 28 hpf (Figure 1-5B). The anterior, leftward swelling gives rise to liver 
bud that aligns with the first somite along the dorsal-ventral axis. The posterior, 
rightward bulge contributes to pancreas primordium at the level of fourth somite (Field et 
al., 2003b). One dispute on this initial morphogenetic process was raised by Wallace and 
Pack (Wallace and Pack, 2003) in which they proposed that, instead of budding out from 
gut tube, the liver progenitor cells actually arise from rostral endoderm at about 21 hpf 
before migrating to assemble to gut (Wallace and Pack, 2003). In stage II, by 34 hpf, liver 
cells undergo rapid proliferation, building up a distinct physical bud (Figure 1-5C). 
During the following stage III, the liver continues to expand while a furrow is gradually 
formed between the liver bud and the esophagus. The hepatic duct connects the liver bud 
and the intestine bulb by 50 hpf (Figure 1-5D). In the subsequent growth phase, the 
nascent liver dramatically increases cell mass and changes its shape (Field et al., 2003b).  
During stage I and II of budding, a morphogenetic process called gut looping occurs 
where the gut rod undergoes a leftward bend that drives the liver bud to the left side of 
the body. Horne-Badovinac et al found that gut looping is driven by a simultaneous 
autonomous asymmetric lateral plate mesoderm (LPM) migration, and this LPM 
displacement is dependent on the epithelial structure of LPM and asymmetric nodal 
signaling (Horne-Badovinac et al., 2003). Unlike in mouse, the endothelial cells do not 
invade the newly specified hepatoblasts in zebrafish. Studies in the Tie2-GFP transgenic 
line showed that the GFP labeled endothelial cells are present in the proximity of liver 
bud at 36 hpf and only migrate into liver at 60 hpf and vascularize whole liver by 72 hpf 
 41
(Field et al., 2003b). This observation is in accordance with the fact that the zebrafish 









Figure 1-5 Stages of liver organogenesis in the zebrafish gutGFP embryos 
(A) The digestive system develops from a solid endoderm rod at 24 hpf. (B) The liver 
(arrowhead) and pancreas (asterisk) start budding from the intestinal rod between 24 
and 28 hpf. (C) Along with gut looping, the liver bud grows toward the left side. The 
swim bladder (arrow) starts to bud from the intestinal bulb primordium at 34 hpf. (D, E) 
These organ buds continue to expand as shown in 46 hpf and 72 hpf. (A-E) Ventral 
views with anterior to the top. enP, endocrine pancreas; exP, exocrine pancreas; GB, 
gall bladder; IB, intestinal bulb; L, liver. Adapted from Field et al., 2003b. 
 
 
1.4.2.2 Molecular mechanisms of liver development  
The gut GFP transgenic line has indeed facilitated our understanding of liver 
development in zebrafish from a morphological perspective. However being still a 
relatively new model organism after all, (most of the molecular mechanisms underlying 
liver organogesis in zebrafish remain partially solved or totally unsettled) the study of 
liver organogenesis in zebrafish needs time to reach the maturity as attained by the mouse 
system. Fox and Gata factors are involved in the acquisition of competency for foregut to 
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take hepatic cell fate in mouse. All three Fox gene, foxa1, foxa2 and foxa3, are expressed 
in a pan-endoderm manner during early hepatogenesis in zebrafish (Odenthal and 
Nusslein-Volhard, 1998). Unfortunately, the functions of these genes in liver 
development  remain highly speculative in the characterization of mutants and morphlino 
knock down embryos (Rastegar et al., 2002; Seiliez et al., 2006; Norton et al., 2005). The 
zebrafish mutant faust is a null allele of gata5, and faust mutant displays multiple defects 
in the development of endodermal organs including the liver, intestine and islet (Reiter et 
al., 2001). Specifically, faust mutant has much less endoderm cells than wildtype at the 
end of gastrulation (Reiter et al., 1999; Reiter et al., 2001), suggesting that the faulty liver 
development phenotype in faust/gata5 is probably a consequence of failure of endoderm 
formation. An additional interesting characteristic of the mutant is that the expression of 
gata5 is restricted in intestine, not in liver. Two other gata genes, gata4 and gata6 
display pan-endoderm expression pattern during hepatogenesis in zebrafish (Holtzinger 
and Evans, 2005; Shin et al., 2007). Due to redundancy, single gene knock-down results 
in partially impaired hepatoblast specification and hepatocyte differentiation. Depletion 
of both factors leads to severe disrupted hepatic specification and resulted in a complete 
block of differentiation (Holtzinger and Evans, 2005; Shin et al., 2007), demonstrating 
that the function of Gata4 and Gata6 are conserved in both mouse and zebrafish. Due to 
lacking data on Fox and Gata factors binding to promoters of hepatic genes in zebrafish, 
it is uncertain if these factors engage in the gain of hepatic competency as they do in 
mouse. 
 
1.4.2.3 Signaling molecules and transcription factors 
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Several mesodermal inductive signals including Fgfs from cardiac mesoderm and Bmps 
from STM (Jung et al., 1999; Rossi et al., 2001) are essential to hepatic specification in 
mouse. The above two signaling pathways have also been shown to be important for liver 
development in zebrafish, though the tissue origins producing these signals are unclear. 
Shin et al. presented the first genetic data showing that blocking of the signaling by 
inducing the expression of heat shock promoter driven dominant negative forms of either 
Fgfs or Bmps receptors at 18-somite stage results in failure of hepatic specification.  
In addition, they also demonstrated that the forced expression of bmp2b could partially 
rescue the hepatic specification in embryos lacking Fgfs signaling (Shin et al., 2007). 
Excitingly, characterization of mutant prometheus (prt), a liverless mutant obtained in a 
forward genetic screen, reveals the third novel mesodermal inductive signal for hepatic 
specification. The prometheus locus was identified by the positional cloning and was 
found to encode a Wnt2b homologue and the signal exerts its function through a 
canonical pathway (Ober et al., 2006). The transcripts of wnt2bb are found enriched in 
the lateral plate mesoderm (LPM) which is in close contact with the liver bud during 
hepatogenesis (Horne-Badovinac et al., 2003; Ober et al., 2006). This physical proximity 
suggests that LPM may serve as the source of inductive signals for hepatic specification. 
Retinoic acid (RA) signaling has been reported to be necessary for liver specification. 
Complete loss of hepatic and pancreatic markers expression were demonstrated in RA-
deficient mutant neckless or embryos treated by pan-RA receptor antagonist BMS493 
(Stafford and Prince, 2002). Exogenous RA administration results in anterior expansion 
of the liver and pancreas, suggesting that retinoic acid signaling contributes to anterior-
posterior body planning to regulate the liver development (Stafford and Prince, 2002). 
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Underdeveloped liver and pancreatic islet is one of the phenotypes in vhnf1/hnf1β mutant. 
Sun and Hopkins hypothesized that vhnf1 regulated the regional specification of liver 
primordium (Sun and Hopkins, 2001). An unknown factor secreted by endothelial cells is 
indispensable for early liver bud growth in mouse (Matsumoto et al., 2001). Surprisingly, 
the examination of zebrafish cloche mutant which is defective in endothelial cells 
differentiation reveals that liver development is relatively normal in the absence of 
endothelial cells (Field et al., 2003b). This result reflects the fact that endothelial cells 
reside closely to the liver bud at relatively late stage (Field et al., 2003b). In mouse, two 
transcription factors, Hhex and Prox1, are reported to be involved in the early liver bud 
formation (Keng et al., 2000; Sosa-Pineda et al., 2000; Hunter et al., 2007; Martinez 
Barbera et al., 2000). Consistent with the mouse data, both hhex and prox1 genes are 
expressed in the developing liver and serve as the earliest hepatoblast markers in 
zebrafish (Wallace et al., 2001; Liu et al., 2003; Ober et al., 2003). In hhex knock down 
morphants, the liver size is dramatically reduced at 50 hpf indicating the conserved role 
of the gene in liver bud growth (Wallace et al., 2001). Regarding the role of prox1, 
unfortunately, in the report of prox1 knockdown, liver development was not recorded 
because it was not the emphasis in the study (Liu et al., 2003). Surprisingly, liver 
initiation is normal in sonic hedgehog signaling deficient mutant sonic you (syu) (Wallace 
and Pack, 2003) although Hedgehog signaling (Shh) appeared to be a positive regulator 
of endocrine pancreas development in zebrafish (Roy et al., 2001; diIorio et al., 2002). 
Interesingly, shh overexpression results in a great loss of hhex expressing hepatoblast at 
26 and 34 hpf and the liver size can be recovered by 50 hpf (Wallace and Pack, 2003), 
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proposing that sonic hedgehog signaling is a negative regulator in the early liver 
development.  
Besides the signaling molecules and transcription factors identified in the hepatic 
specification and early liver bud formation, a number of genes have also been cloned by 
forward genetic screening, defining liver bud growth and hepatocyte differentiation. 
From the Boston’s large-scale screen on about 500 lines focusing on digestive organs at 
5-6 day post fertilization (dpf), nine mutations, including two causing hepatic 
degeneration, were found to perturb gastrointestinal development (Pack et al., 1996). In 
the Tubingen screen, four mutants were identified with liver development defects, 
possessing either abnormally enlarged liver grey granules at 3 dpf or accumulation of red 
blood cells in the liver at 4 dpf (Chen et al., 1996). Allende et al. reported a mutant with a 
provirus insertion in a novel gene pescadillo (pes) which expresses in liver bud at 2 dpf. 
The inactivation of pes gene leads to failure of liver expansion from 3 dpf, probably due 
to the disruption of cell cycle progression (Allende et al., 1996). Another proviral 
insertion in a novel gene digestive-organ expansion factor (def) causes the loss of 
function of the gene which is expressed in a pan-endoderm- specific manner from 2 dpf 
(Chen et al., 2005). Further investigation revealed that the hypoplastic digestive organs 
(except pancreatic islet) phenotype in these mutants are a consequence of cell cycle arrest 
triggered by the selective cell-autonomous up-regulation of Delta113p53 from 3 dpf 
(Chen et al., 2005). Similar phenotypes were also reported in an ENU-induced mutant nil 
per os (npo) (Mayer and Fishman, 2003). The gene npo encodes a conserved protein with 
multiple RNA recognition moifs which promote organ cytodifferentiation (Mayer and 
Fishman, 2003). The small size liver was found in the homozygous proviral insertion 
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mutation in gene ubiquitin-like protein containing PHD and ring finger domains-1 
(uhrf1), a cell cycle regulator and transcriptional activator of topoisomerase IIα (Sadler et 
al., 2007).  
Interestingly, liver regeneration is impaired in heterozygous uhrf1 mutant after partial 
hepatectomy (Sadler et al., 2007). In addition to these documented mutants in the 
literature, most of the liver defective alleles obtained in 2 other genetic screens (Stainier’s 
and our lab) are affected in the liver bud growth and hepatic differentiation stages (Huang 
et al., unpublished data; personal communication with Stainier). While numerous small 
size liver mutants were identified, Sadler et al. carried out a genetic screen for 
hepatomegaly (big liver) mutants in zebrafish (Sadler et al., 2005). Seven proviral 
insertion mutants were identified including three resembling different liver diseases. 
Mutation in the class C vacuolar sorting protein Vps18 imitates hepatic symptoms of 
arthrogryposis- renal dysfunction- cholestasis syndrome (ARC), which is related to the 
mutation in another vacuolar sorting protein Vps33b. Both proteins play an essential role 
on protein trafficking (Gissen et al., 2004). The second mutant has an insertion in the 
tumor suppressor gene neurofibromatosis 2 (nf2) and causes hepatomegaly and 
choledochal cysts. The third one is a novel gene, foie gras (fgr). Although the 
mechanisms remain unclear, the fgr mutant is the first reported non-mammalian fatty 
liver disease model (Sadler et al., 2005). Cumulatively, the factors that have been 
described so far in promoting hepatoblast proliferation and differentiation in zebrafish 
belong to quite a diverse nature. Early morphogenesis of the biliary system in zebrafish is 
not as well-documented as that in mouse. Immunohistochemistry experiments using bile 
duct cell specific markers reveals that, as in mouse, structures of extrahepatic bile ducts 
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(EHBD), hepatic, cystic, common bile ducts and gallbladder, together with 
extrapancreatic duct, form a ductal system linking the zebrafish liver and pancreas with 
the intestine at 80 hpf, spanning the liver growth stage (Field et al., 2003b; Lorent et al., 
2004; Dong et al., 2007). As for intrahepatic bile ducts (IHBD), unlike in human and 
mouse where a bile duct is bundled with a portal venule and a hepatic arteriole to form a 
portal triad located at the corner of the liver lobule; in the zebrafish, the nascent bile duct 
cells present in the embryonic liver at 60 hpf and 70 hpf, and eventually distributed 
randomly in the liver (Lorent et al., 2004). Despite of the apparent histological difference 
between zebrafish and mammals, substantial evidence existed supporting the 
conservation of molecular mechanisms of biliary morphogenesis. Onecut transcription 
factors, Hnf6 and Onecut2 (Oc2), cooperate to regulate the development of IHBD 
through Hnf1β (also known as vHnf1) in mouse (Coffinier et al., 2002; Clotman et al., 
2002; Clotman et al., 2005). Morphlino knockdown of hnf6 similarly affects the 
development of IHBD in zebrafish with paucity of bile ducts growth, although relatively 
different to the ectopic formation of biliary cells in the mouse liver. Injected vhnf1 
mRNA restored the bile duct development in hnf6 morphants, presenting the first genetic 
evidence on the relationship between hnf6 and vhnf1 in zebrafish (Matthews et al., 2004). 
Recently, another Onecut transcription factor onecut3 (oc3) was found to regulate IHDB 
in the upstream of vhnf1, postulating oc3 the functional ortholog of mammalian hnf6 
(Matthews et al., 2008). One of the downstream targets of the hnf6/vhnf1 cascade is 
aforementioned (section 1.4.2.2) vps33b, a gene encoding a class C vacuolar sorting 
protein responsible for the ARC syndrome (Matthews et al., 2005). Morphlino mediated 
vps33b knockdown causes paucity of the bile ducts which is one of the characteristic 
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defects in ARC. Further inquiry showed that the expression level of vps33b was 
downregulated in hnf6 and vhnf1 morphants, and vHnf1 was found to bind the promoter 
of vps33b directly (Matthews et al., 2005). Compound knockdowns of jagged and notch 
genes phenocopy defects in jagged1 mutation caused Alagille syndrome (AGS), with 
phenotypes of abnormal development of hepatic and pancreatic duct cells. Consistently, 
over-activation of the Notch signaling pathway was later found to result in ectopic 
formation of biliary cells in the liver (Lorent et al., 2004). Recently, Dong et al reported a 
mutation in fgf10 that resulted in dysmorphic of EHBD and extrapancreatic duct (which 
are termed hepatopancreatic ductal system) (Dong et al., 2007). Ffg10 signaling in the 
neighboring mesenchyme refines proper ductal morphogenesis by repressing 
hepatopancreatic ductal system to undergo hepatic and pancreatic differentiation (Dong et 
al., 2007). Apart from the extensive genetic data built up by a wide diversity of factors 
and signaling molecules, genomic effort are paying off as well. Cheng et al. identified 
129 liver enriched genes using zebrafish affymetrix microarray technology, among which 
69 were found to be also enriched in the embryonic liver (Cheng et al., 2006). 
Bioinformatics analysis revealed that the majority of 51 liver enriched genes had more 
than one putative binding sites of Hnf1, Hnf3, Hnf4 or Hnf6 in their promoter regions, 
suggesting the existence of a Hnf network in the regulation of liver enriched genes 
(Cheng et al., 2006). Another recent application of microarray technology is the 
demonstration of gene expression signature conservation between zebrafish and human 
liver tumors and tumor progression, proposing zebrafish as a promising liver tumor 




Ribosome, responsible for protein manufacturing in all living cells, is a large 
ribonucleoprotein complex made up of 65% ribosomal RNAs (rRNA) and 35% 
ribosomal proteins. Eukaryotes have 80S ribosomes, each consisting of a small (40S) and 
large (60S) subunit. Their large subunit is composed of a 5S RNA (120 nucleotides), a 
28S RNA (4700 nucleotides), a 5.8S subunit (160 nucleotides) and ~49 proteins. The 40S 
subunit has a 1900 nucleotide (18S) RNA and ~33 proteins (The Molecular Biology of 
the Cell, 4th Edition. Bruce Alberts, et al. Garland Science (2002) Chapter 6: How cells 
read the genome – from DNA to protein). Synthesis and processing of rRNAs and 
assembly of ribosomes in eukaryotic cells occur in the nucleolus and follow a complex 
pathway where rRNA is transcribed, processed, and assembled with ribosomal proteins to 
produce ribosomal subunits. The substrate for rRNA processing is a large 
ribonucleoprotein complex containing a multiple of ribosomal proteins and accessory 
nucleolar trans-acting factors that associate with the nascent pre-rRNA (reviewed by 
Kressler et al., 1999). rRNA processing has been most extensively studied in the yeast 
Saccharomysces cerevisiae and many trans-acting factors, both proteins and 
ribonucleoproteins, required for the process have been characterized in the organism as 
well. One of them is Rcl1p, a putative endonuclease that is essential for pre-rRNA 
processing at specific sites of the ribosomes (Billy et al., 2000). A year later, Bms1p was 
discovered by the same group via a yeast two-hybrid screen using Rcl1p as the bait 
(Wegierski et al., 2001). Like Rcl1p, Bms1p is an evolutionarily conserved nucleolar 
protein required for pre-rRNA processing at specific ribosomal sites. By having structural 
features common to the regulatory GTP/GDP binding protein (G proteins) at the N-
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termini domain and later was shown to indeed, function as a GTPase for the biogenesis of 
the 40S ribosomal subunits (Karbstein et al., 2005). Almost the entirety of Bms1l 
functional study to date is focused on its conserved role of GTPase in ribosomal assembly, 
where a large proportion of the investigation is biochemical in nature, exploring the 
ordering and kinetics of complex formation and disassociation by components 
reconstitution assays.  
 
1.6 Rationales and aims of the project 
It is apparent that zebrafish has yet to be explored to its full potential in liver 
organogenesis and data parallelism between mouse and zebrafish reported so far has been 
encouraging. In addition, the recent discovery of new components such as from the 
Wnt2bb pathway (Ober et al., 2006), of which have not been previously described in the 
mouse system further emphasizes the unique advantage of zebrafish in this field. 
Therefore one of the obvious directions to fully exploit the genetic strength of the 
organism is to generate more mutants to define the process. Saturating the process with 
mutants will undoubtedly allow thorough dissection of liver development genetically. A 
mutant, sq163, exhibiting a small liver phenotype is the highlight in this thesis. The 
molecular cloning and downstream analysis of this mutant will be discussed in 






Chapter 2   Materials and methods 
 
This chapter details the various genetic, molecular and cellular protocols used in this 
work and the respective materials and instruments involved. The project began with 
mapping of sq163, one of the small liver mutants. Initial effort involves the generation of 
mapping population by crossing sq163 heterozygote (AB background) with polymorphic 
ecotype WIK line. The resultant sq163 heterozygotes in F1 were mated for producing 
homozygous mutant embryos for mapping (which was divided into 3 stages: rough, 
intermediate and fine mapping). During mapping, whole-mount in situ hybridization 
(WISH) and bulk segregation analysis (BSA) were used to determine the linkage group 
(LG) harboring the mutation. Subsequent candidate gene approach to identify the 
mutation site relied heavily on molecular biology tools that involve cloning and 
sequencing of the exons of the genes fallen within the defined genomic DNA fragment by 
fine mapping. Eventually, the mutant gene identity was confirmed by wild-type transcript 
rescue and morpholino mimicking experiments. Phenotypic characterization of sq163 
involved the use of multiple molecular markers. Proliferation and cell death assays were 
also carried out as a first step to dissect the possible mechanisms responsible for the 
endodermal defects. Naturally, none of these would have been possible without the 
know-how of fish stocks maintenance and embryos manipulations throughout the project.  
 
2.1 Zebrafish 
2.1.1 Fish strains and maintenance 
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Zebrafish (Danio rerio) ABtü strain was used as the wild-type line for routine crossing 
and was the origin for sq163. Another wild-type ecotype, WIKC line, was used in 
generating a polymorphic mapping population. Adult zebrafish were raised and 
maintained in the central fish facility (0.012% sea salt in distilled water) in IMCB 
according to standard procedures (Sprague et al., 2001).  
 
 
2.1.2 Collection of fertilized eggs 
To obtain synchronized zebrafish embryos, one male fish and one female fish were put 
into a crossing tank, separated by a separator at the evening just before the actual crossing 
day. The next morning when light comes, the separator was removed to allow mating. 
The fertilized eggs were collected in egg water (0.03% sea salt in distilled water) and 
raised at 28.5°C. The egg water was supplemented with 0.03 mM methylene blue to 
suppress growth of undesirable algae, which would otherwise lead to lethality of the 
unhatched embryos. The developmental stages of an embryo were determined based on 
somite numbers and recorded in hours post fertilization (hpf) or days post fertilization 
(dpf) as previously described (Kimmel et al., 1995) (Figure 2-1). Embryos for whole-
mount in situ hybridization analyses were treated with 0.03% phenylthiourea (PTU, 
Sigma, Cat. No. P7629) between 12 hpf to 24 hpf to inhibit melanin pigment formation, 







Figure 2-1 Developmental stages of the zebrafish embryo. Adapted from 




2.1.3 Collection of unfertilized eggs 
Unfertilized eggs were collected for microinjection and RNA extraction purposes. One 
male and one female fish were separated by a separator in a crossing tank as normal. The 
separator was removed on the next morning but before the female fish was laying eggs, it 
was removed from the male and put into egg water containing ethyl 3-aminobenzoate 
methanesulfonate salt (75 mg/L or less, Sigma, Cat. No. E10521). Between 2-5 minutes, 
the anesthetized female fish was put on a clean petri dish to release unfertilized eggs by 
softly massaging the abdomen of the female fish.  Unfertilized eggs were quickly 
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collected. The sedated fish was carefully put back into water again to regain 
consciousness. 
 
2.2 General DNA manipulation 
2.2.1 Gene Cloning 
2.2.1.1 Polymerase chain reaction (PCR) 
There are 4 versions for PCR carried out in this project, which mainly differed by the 
type of Taq and cycling conditions based on specific purposes: (i) routine PCR (ii) high 
fidelity PCR (iii) mapping PCR and (iv) genotyping PCR. Routine and high fidelity PCR 
will be described in this section while the other two, being related to mapping will be 
detailed in later section specific to mapping (Section 2.4.3.2). 
Routine reaction was reconstituted in a 0.2 ml PCR tube in a total volume of 50 μl as 
follows: 5 μl 10X PCR reaction buffer, 1 μl 10 mM dNTPs, 1 μl 10 μM of specific 
primers, less than 0.5 μg template DNA and 0.5 μl Taq (Qiagen Cat. No. 201223), after 
which was subjected to program: 94°C for 3 minutes; 35 cycles of 94°C for 30 seconds, 
58°C for 30 seconds  72°C for 1-2 minutes; 72°C for 10 minutes. High fidelity enzyme 
system was used to amplify >3kb error-free fragments used for rescue experiments. A 
typical 50 μl reaction is comprised of 5 μl 10X PCR reaction buffer, 2.5 μl 10 mM 
dNTPs, 2 μl 10 μM of specific primers, less than 0.5 μg template DNA and 0.5 μl 
AccuTaq (Sigma Cat. No. D8054). The cycling parameters for this enzyme was as 
followed: 98°C for 30 seconds; 30 cycles of 94°C for 15 seconds, 56°C -58°C for 20 
seconds  68°C for 3-4 minutes; 68°C for 10 minutes. For both types of PCR, the 
annealing temperature was usually adjusted to 5℃ below the calculated melting 
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temperature of primers, Tm (4(G+C) + 2(A+T)) while the extension time was determined 
by allowing 1 minute per kb amplicon expected. The primers and their annealing 
temperatures are summarized in Table 2-1. All amplification was carried out in a 
Programmable Thermal Controller (Model PTC-100, MJ Research). Typically 1/10 PCR 
product were analyzed by electrophoresis on 1% agarose gel (Invitrogen Cat. No. 15510-
027) by electrophoresis using the 1X TAE buffer system [40 mM Tris-acetate, 20 mM 
sodium acetate, 1 mM EDTA, pH 8.2]. 
 
2.2.1.2 Purification of PCR product/DNA fragments  
High Pure PCR product purification kit (Roche, Cat. No. 11732668001) was used to 
purify DNA solution according to the manufacturer’s instruction. QIAEX® II Gel 
Extraction Kit (Qiagen, Cat. No. 20021) was used to purify DNA pieces from excised 
agarose gel as described by the manufacturer. 
 
2.2.1.3 Plasmid DNA extraction and glycerol stocks preparation 
A single bacterial colony was picked from LB plate and inoculated into 5-15 ml LB 
medium [1% (W/V) Bacto-tryptone, 0.5% (W/V) yeast extract, 1 mM NaCl, pH 7.0] 
containing appropriate antibiotics [ampicillin 100 μg/ml or kanamicin 50 μg/ml]. The 
culture was incubated overnight at 37°C with vigorous shaking until the next morning, 
200 μl of the overnight culture was mixed with the same volume of 50% glycerol and 
stored at -80°C as a stock for future bacterial revival. The remaining bacterial culture was 
spun down at the maximum speed for 3 minutes in a centrifuge (Sigma laboratory 
centrifuges 3K30). After removal of the LB supernatant, the plasmid was extracted from 
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the pellet using QIAGEN Plasmid Mini Kit (QIAGEN, Cat. No. 12125) according to the 
manufacturer’s instruction. 
 
2.2.1.4 Ligation of DNA inserts into plasmid vectors 
For TA cloning, ligation of purified PCR fragment into pGEM®-T/pGEM®-T Easy vector 
(Promega, Cat. No. A3600 and A1360) was performed as described in the manufacturer’s 
manual. Other vector backbones were digested by appropriate DNA restriction enzymes 
from New England Biolabs and then dephosphorylated by SAP (Shrimp Alkaline 
Phosphatase, Roche, Cat. No. 11758250001). After purification of the linearized vector 
DNA and insert fragment as described (section 2.4.1.2), ligation reaction was set up at the 
molar ratio of 3:1 (insert DNA: linearized vector DNA) using either the T4 DNA ligase 
supplied in Rapid DNA Ligation Kit (Roche, Cat. No. 11635379001), or the pGEM®-T 
Easy vector system (Promega, Cat. No. A1360). Detailed procedures were performed 
following the instructions provided by the manufacturers.  
2.2.1.5 Transformation of DH5α competent cells with plasmids or ligation products 
using the heat-shock method 
2.2.1.5.1 E. coli strain 
In this project, the E. coli strain used for both plasmids propagation and cloning was 
DH5α. It was stored in 25% glycerol/LB [1% (W/V) Bacto-tryptone, 0.5% (W/V) yeast 
extract, 1 mM NaCl, pH 7.0] at -80°C. Before being used for competent cells preparation, 
it was recovered on a LB agar plate [1% (W/V) Bacto-tryptone, 0.5% (W/V) yeast extract, 
1 mM NaCl, pH 7.0, 1.5% (W/V) agar], with the appropriate antibiotic. 
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2.2.1.5.2 Preparation of DH5α competent cells  
A single colony of DH5α from a freshly streaked LB plate was picked up and inoculated 
into 250 ml of SOB medium in a 2-liter flask to grow at 18°C with vigorous shaking 
(200-250 rpm) until the OD600 reached to 0.6. After an incubation of 10 minutes on ice, 
the cells were spun down at 2500 g in Beckman J-6B centrifuge for 10 minutes at 4°C. 
The pellet was resuspended in 80 ml of ice-cold TB medium [10 mM Hepes, 15 mM 
CaCl2, 55 mM MnCl2, 250 mM KCl. pH 6.7], followed by a second incubation on ice for 
10 minutes. The centrifugation was repeated, after which the pellet was resuspended in 
20 ml of TB with gentle swirling. Finally, DMSO was added to this cell suspension at a 
final concentration of 7% (V/V), followed by a final 10-minute incubation on ice. The 
cell suspension was dispensed into aliquots of 50 ul in PCR stripe-tubes and immediately 
frozen by immersing in liquid nitrogen. The frozen competent cells were stored at -80°C 
for long- term usage. 
 
2.2.1.5.3 Heat-shock transformation     
Competent cells were thawed on ice and 50 μl of cells were transferred to a chilled 1.5 ml 
eppendorf tube. 1 ng of plasmid DNA or 1-5 μl of ligation product was added to 1.5 ml 
tube and gently mixed with competent cells. The mixture was incubated on ice for 30 
minutes, and then heat-shocked without agitation at 42°C for 90 seconds, followed by 
immediate plugging into ice for 2 minutes. After that, 1 ml liquid of LB medium was 
added and the cells were recovered at 250 rpm at 37°C for 45 minutes. The cells were 
then spun down at 3,000 g for 5 minutes. After discarding about 900 μl supernatant, the 
pellet was resuspended in the remaining LB, and plated onto LB plates with appropriate 
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antibiotics [ampicillin 100 μg/ml or kanamicin 50 μg/ml， X-gal 40μg/ml and IPTG 0.1 
mM, ] and incubated overnight at 37°C.  
 
2.2.2 DNA sequencing 
DNA sequences were determined using ABI BigDye® Terminator Version 3.1 (Applied 
Biosystem, P/N 4337458), following the protocols from the manufacturer. A 10 μl 
sequencing reaction comprising of 4 μl BigDye, 1.0 μl 3.2 mM Primer, ~200 ng plasmid 
DNA and H2O or, 4 μl BigDye, 0.7 μl 3.2 mM Primer, ~3 ng PCR product and H2O. 
Thermocycling parameters for PCR product sequencing were composed of an initial 
denaturation step of 3 minutes at 95°C, followed by 35 cycles of 95°C for 30 seconds, 
52.5°C for 10 seconds and 60°C for 4 minutes. For plasmid DNA sequencing, the 
conditions only consisted of 35 cycles of 96°C for 10 seconds, 50°C for 5 seconds and 
60°C for 4 minutes. The finished sequencing products will be sent to the IMCB’s in-
house Sequencing Facility for base calling. 
 
2.2.3 Site-directed mutagenesis 
Site-directed mutagenesis in DNA sequence was performed based on a modified PCR 
method. Specific primer pairs (Table 2-1) were designed to harbor either a stop codon or 
a specific amino acid. To create a stop codon-containing fragment, a PCR reaction was 
set up with a normal forward primer designed about 200 bp away from the point to be 
mutagenized and the stop codon harboring primer (reverse). Another reaction was made 
up of a normal reverse and the stop codon harboring forward primers. These two 
reactions were purified (Section 2.2.1.2) and 5ng of each was taken to set up a third PCR 
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reaction using nested primers, amplifying a fragment with the desired mutation. The 
fragment was purified and cloned via appropriate restriction sites into a plasmid 
backbone containing the rest of the necessary sequence. Similar procedures were carried 
out to create a specific amino acid mutant clone. All PCR reactions were set up in 50 μl 
using high fidelity DNA polymerase as described (Section 2.2.1.1).  
 
2.2.4 Zebrafish genomic DNA extraction 
2.2.4.1 Genomic DNA extraction from adult zebrafish 
``Adult zebrafish needs to be starved for one to two days before the extraction to 
minimize contamination from the feed’s genomic DNA, which is brine shrimp. The 
zebrafish was transferred into a Petri dish and anesthetized with ice or in egg water 
supplemented with ethyl 3-aminobenzoate methanesulfonate salt (75 mg/L, Sigma, Cat. 
No. E10521). It was sacrificed with internal organs removed and the remaining body was 
rinsed briefly with PBST (1 X PBS, 01% Tween 20). The fish was weighed and 
transferred into 10 ml zebrafish lysis buffer [100 mM Tris-HCl (pH 8-8.5), 200 mM NaCl, 
0.2% SDS, 5 mM EDTA, supplemented with 1/200 volume Proteinase K (FINNZYMES, 
Cat. No. F-202L, to be added prior to use)]. After an overnight incubation at 55°C with 
gentle rotation, the mixture was spun at 10,000 g for 15 minutes. The debris was 
discarded while the supernatant was extracted in turn with the same volume of a series of 
solutions: phenol (pH 8.0), 1:1 phenol (pH 8.0) /chloroform and chloroform. For each 
extraction, the mixture was gently shaken for 10 minutes after the addition of the specific 
solution. The well separated upper phase obtained after a 10-minute spin at 10,000 g was 
subjected to the next solution in line, until a final protein-free and organic solvent-free 
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upper phase was obtained. An equal volume of isopropanol was added to the extracted 
upper phase for genomic DNA precipitation. After gentle inverting the mixture for 
several times, strings of cloudy white DNA were collected using a clean inoculation stick, 
and washed twice with 1.5 ml 70% Ethanol. The genomic DNA was dissolved in 1X TE 
buffer [10 mM Tris-HCl, 1 mM EDTA, pH 8.0] (400 μl/0.3 g of tissue) over several days 
at 4°C. This DNA solution can be used for PCR analysis, or stored in aliquots in -20°C.  
 
2.2.4.2 Isolation of genomic DNA from embryos or scales of adult zebrafish 
Embryos or scales picked from adult zebrafish by forceps were individually transferred 
into 0.2 ml PCR tubes or 96-well plates. To extract genomic DNA from embryos, 50 μl 
embryo lysis buffer [1X TE supplemented with 1/40 volume Proteinase K (FINNZYMES, 
Cat. No. F-202L, to be added prior to use] was added to each sample. For extraction of 
genomic DNA from scales of an adult fish, 15 μl embryo lysis buffer was added to each 
scale sample. They were then incubated in a Thermal Controller (Model PTC-100, MJ 
Research) either at 55°C for 14 hours or at 65°C for 2 hours for lysis,  followed 94°C for 
20 minutes for Proteinase K inactivation (Finnzymes, Cat. No. F-202L). After spinning 
down the debris at 1,000 rpm for 5 minutes, the supernatant was used directly as a PCR 
template or stored at 4°C for future use. 
 
2.2.5 Preparation of ‘home-made’ Taq 
A single colony of E. coli cells containing Taq recombinant plasmid was inoculated into 
10 ml LB medium containing 100 μg/ml carbenicillin and allowed to propagate overnight 
at 37°C with vigorous shaking. The next morning, the overnight culture was diluted 1 
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into 1000 into 100 ml fresh LB/carbenicillin medium and continued to grow at 37°C with 
shaking until the OD600 reached 0.3-0.4. A final concentration of 0.5 mM IPTG was 
added to the culture and incubated for an additional 16 hours at 37°C to induce protein 
expression. After that the cells were harvested by centrifuging at 4,000 g for 15 minutes 
and the pellet was resuspended in 3 ml of Buffer A (50 mM Tric-Cl, pH 7.9, 50 mM 
glucose, 1 mM EDTA, 4 mg/ml lysozyme was added prior to use). After an incubation of 
15 minutes at room temperature, 3 ml of Buffer B (10 mM Tric-Cl, pH 7.9, 50 mM KCl, 
1 mM EDTA, 0.5 % Tween-20, 0.5 % NP40) was added and a further one-hour 
incubation was carried out with gentle shaking in a waterbath set at 75°C. Once lysis was 
completed, the mixture was spun at 12,000 g for 10 minutes at 4°C. The supernatant 
containing the enzyme was collected and diluted with pre-chilled Storage Buffer 1 (50 
mM Tric-Cl, pH 8.0, 100 mM NaCl, 0.1 mM EDTA, 0.5 mM DTT, 1 % Triton X-100, 
50 % glycerol) very slowly in a 1:1 ratio, with continuously stirring. After that, a second 
similar dilution process was achieved by adding Storage Buffer 2 (50 mM Tric-Cl, pH 
8.0, 100 mM NaCl, 0.1 mM EDTA, 0.5 mM DTT, 1 % Triton X-100, 75 % glycerol). 
The final mixture was aliquoted and kept at -20°C, ready for use. 
2.3 General RNA manipulations 
2.3.1 RNA extraction from embryos or adult zebrafish 
For every 100 mg sample, 1 ml TRI Reagent (Molecular Research Center, Inc. Cat. No. 
TR118) was added for homogenization. After that, 0.2 ml of chloroform was added and 
shaken vigorously for 15 seconds, followed by incubation at room temperature for 2-15 
minutes. After centrifugation for 15 minutes at 12,000 g at 4°C, the upper aqueous phase 
was transferred to a new tube. The chloroform extraction step was repeated to get higher 
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RNA quality. RNA precipitation was achieved by adding 0.5 ml of isopropanol followed 
by mixing and incubation at room temperature for 5-10 minutes. After centrifugation at 
12,000 g for 8 minutes at 4-25°C, the pellet was washed with 75% ethanol (V/V), 
followed by another centrifugation for 8 minutes at 4°C. The final RNA pellet was either 
air dried for 3-5 minutes and then dissolved in nuclease-free water, or stored as a pellet in 
70% ethanol at -80°C. RNA concentration and yield were determined using 
spectrophotometer (ND-1000, NanoDrop) and the quality was evaluated by 
electrophoresis in 1.3% denaturing gel (Section 2.5.6.3) 
 
2.3.2 Removal of genomic DNA 
To remove contaminating remnant genomic DNA in total RNA preparations, a 200 μl 
reaction consisting 20 μg total RNA, 1X in vitro transcription reaction buffer (Roche, Cat. 
No. 11 465 384 001) and 1-2 Units of RNase-free DNase I (Roche, Cat. No. 10 776 785 
001) was set up. After an incubation at 37°C for 20 minutes, the total RNA was purified 
using the RNeasy® Mini Kit as described in the manufacturer’s instruction (QIAGEN, 
Cat. No. 74106). 
 
2.3.3 mRNA isolation 
Oligotex® mRNA Midi Kit (QIAGEN, Cat. No. 70042) was used to purify mRNA from 
total RNA following the protocols provided by the manufacturer.   
 
2.3.4 Reverse Transcription PCR (RT-PCR) 
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Reverse transcription PCR was performed on total RNA to obtain cDNA of interest, 
either full-length or partial sequence. The gene specific primers utilized can be found in 
Table 2-1. The thermocycling programs used were as described in Section 2.4.1.1. 
 
2.3.4.1 One-step RT-PCR 
 The Titan One Tube RT-PCR system (Roche, Cat. No. 11 855 476 001) allows the 
synthesis of first strand cDNA and PCR in a single reaction setup The standard 50 μl RT-
PCR reaction was composed of 10 μl 5X RT-PCR buffer, 1 μl 10 mM dNTPs, 2 μl 10 
μM of specific primers (Table 2-1), 2.5 μl 100 mM DTT, 0.25 μl rRNasin® RNase 
inhibitor (20U/μl, Promega, Cat. No. N251A), 1 μg DNase I-treated total RNA, 1 μl 
enzyme mix and sterile distilled water. The sample was then equilibrated at 50°C for 30 
minutes, followed by PCR.  
 
2.3.4.2 Two-step RT-PCR 
As step one, cDNA was synthesized from DNase I-treated total RNA using 
SuperScriptTMII RNase H- Reverse Transcriptase (Invitrogen, Cat. No. 18064-22). This 
synthesized cDNA was either used immediately or stored at -20°C for one year. During 
the second step, 2 μl of the synthesized first strand cDNA was used in a 50-μl PCR 
reaction.  
 
2.3.5 mRNA synthesized by in vitro transcription 
Capped mRNA was synthesized by in vitro transcription from the pCS2+ vector 
harboring a SP6 promoter and a SV40 polyA signal. The coding sequence of a target 
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gene was cloned into the vector by engineering compatible restriction digestion sites in 
the gene specific primers (Table 2-1). After successfully obtaining an error-free clone, the 
linearized construct was used as a template for capped mRNA synthesis following the 
manufacturer’s instruction of the mMESSAGE mMACHINE® SP6 Kit (Ambion, Cat. 
No.1340). The purified capped mRNA was dissolved in RNase-free H2O at a high 
concentration (more than 1 μg/μl) and aliquoted into small quantities (1–2 μl), and stored 
at -80°C for long-term usage. 
 
2.3.6 Northern Blot analysis 
2.3.6.1 Preparation of DIG-labeled DNA probes 
The PCR method was used to synthesize DIG-labeled DNA probes for Northern Blot 
analysis. Apart from substituting 10 μM dNTPs with 10X PCR DNA DIG Labeling mix 
(Roche, Cat. No. 1636090), other components in this PCR reaction were the same as 
described in Section 2.4.1.1. However, for probes that were more than 1 Kb in length, 
dNTPs was combined with PCR DNA DIG Labeling mix (1 part of DIG Labeling mix 
added to 6 parts of dNTPs (2 mM each)) was used to perform PCR.  At the same time, a 
control PCR was set up using only the normal dNTPs. After purification of the PCR 
products via the High Pure PCR product purification kit (Roche, Cat. No. 11732668001), 
2 μl of labeled and control products were analyzed on 1% TAE agarose gel and the yield 
was estimated by comparing to the fluorescence intensity with that of 1 Kb ladder (New 
England Biolabs, Cat. No. N3232L). 
Before use, the labeled DNA probe being double-stranded, was denatured at 100°C for 10 
minutes followed by immediately ice incubation. It was diluted in pre-warmed DIGTM 
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Easy Hybridization buffer (Roche Cat. No. 1 603 558) to a final working hybridization 
concentration of 25 ng/ml.  
 
2.3.6.2 RNA sample preparation 
For each sample, 10-30 μg total RNA or mRNA was added in 20 μl RNA formaldehyde 
loading buffer (1X MOPS (5 mM NaOAC, 0.02 M MOPS, 1 mM EDTA, pH 7.0), 50% 
deionised formamide, 6.5% Formaldehyde, 50 ng/μl Ethidium bromide). Denaturation 
was achieved at 65°C for 20 minutes, followed by immediate chilling on ice for 5 
minutes. The denaturing gel was prepared as 1.3% agarose dissolved in 1X MOPS and 
2% formaldehyde. 
 
2.3.6.3 RNA gel electrophoresis 
Based on the concentrations determined as described in Section 2.5.1, equal RNA amount 
from different samples were separated by electrophoresis using the denaturing gel at 10-
12 V/cm in 1X MOPS running buffer. A RNA molecular weight ladder (Invitrogen, Cat. 
No. 15620-016) was loaded on the first lane for size reference. After electrophoresis, the 
gel was briefly rinsed with sterile water followed by two washes in 10X SSC for 15 
minutes. RNA was transferred overnight onto Hybond N+ membrane (GE Health care, 
Cat. No. RPN303B) using 10X SSC by capillary action. Transferred RNA was fixed on 
the membrane by a UV crosslinker (Stratalinker, Stratagene) and the RNA quantity and 
quality on this membrane was evaluated by staining with methylene blue staining buffer 
(0.3 M NaOAc pH 5.2, 0.03% Methylene Blue, MRC Cat. No. MB119). During staining, 
a thin layer of methylene blue is laid over the entire surface of the membrane gently. 
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After about 3-5 minutes, the solution is removed followed by rinsing the membrane under 
a small stream of running tap water until the background was clear with distinct stained 
rRNA bands. The membrane was then air-dried.  At this point, the membrane was usually 
scanned for record keeping before proceeding to hybridization. 
 
2.3.6.4. Hybridization and chemiluminescense detection 
The RNA blot was pre-hybridized at 50°C or 68°C for 2 hours in DIGTM Easy 
Hybridization buffer (Roche Cat. No. 1 603 558). The pre-hybridization buffer was 
replaced with the DIG-labeled DNA probe prepared in Section 2.6.7.1, followed by 
overnight hybridization at 50°C. The next day, a series of washes were carried out at 
68°C that include two 5-minute washes in 2X SSC/0.1% SDS (W/V), two 15-minute 
washes in 0.5X SSC/0.1% SDS (W/V) and two 15-minute wash in 0.1X SSC/0.1% SDS 
(W/V).  The remaining steps were carried out at room temperature. The membrane was 
firstly blocked in Roche Blocking Reagent for 30-60 minutes and then incubated in the 
antibody solution (anti-digoxigenin-AP (Roche, Cat. No. 1 093 274) with 1:20,000 
dilution in Roche Blocking Reagent) for 30 minutes. After six washes in Roche washing 
buffer, each for 15 minutes, the membrane was equilibrated in Roche detection buffer for 
3 minutes. The membrane was layered using Ready-to-use CDP-star solution (Roche, Cat. 
No. 12 042 677 001), and incubated for 5 minutes. Finally, hybridization signals present 
on the membrane were detected on an X-ray film (GE Healthcare, Cat. No. RPN3114K) 
developed on a KODAK X-Omat 2000 film processor in the dark room. All the buffers 




2.4.1. Preparation of mapping pairs 
Our mutants were generated in the ABtü strain. A mapping family was generated by 
crossing heterozygous fishes (163-1 and 163-2) from the 4th generation of sq163 with 
wild-type WIK fishes with subtle genetic differences (WIK-A2 and WIK-C5). In total, 
four mapping families were generated (163-1 ♂ X WIK-A2 ♀, 163-2 ♀ X WIK-A2 ♂, 
163-2 ♂ X WIK-C5 ♀, 163-2 ♀ X WIK-C5 ♂). The 4 original sq163 fishes (F0 
generation) were called the grandparents. Upon maturation of F1 fish, crosses were set 
between siblings within each mapping families to identify sq163 heterozygote fishes. 
These fishes, called the parents, were kept as individual mapping pairs. The offsprings 
(F2) generated by these heterozygote fishes were raised to 4 dpf and were phenotypically 
categorized to wildtype siblings (harboring normal size liver) and mutant (with small 
liver) via whole-mount in situ hybridization (WISH) (Section 2.5.3) using the RNA probe 
lfabp (liver fatty acid binding protein) (Her et al., 2003). 
 
2.4.2. Genomic DNA preparation 
All mutant embryos (~25%) identified via WISH were picked out from a majority of 
wildtype siblings (~75%) under a dissection microscope and transferred individually into 
96-well plates with their origins recorded in details. As for the wildtype siblings, a total 
of 26 embryos were picked while the rest was discarded. Typically, at least 1000 
individual mutant embryos are needed for successful positional cloning. As reference, the 
genomic DNA from the grandparents was extracted from their scales (Section 2.4.2.2). 
Those from wildtype siblings and mutants were obtained by direct lysis of the embryos 
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(Section 2.4.2.2). Upon obtaining enough mapping population, the grandparents were 
sacrificed and their genomic DNA is extracted and kept (Section 2.4.2.1). 
 
2.4.3 Rough mapping 
Rough mapping aims to locate the mutation site on a specific linkage group (LG) and a 
protocol known as bulk segregation analysis (BSA) was utilized (Figure 2-2) 

















 Figure 2-2 Schematic illustration of bulk segregation analysis (BSA) 
A good SSLP marker for positional cloning is one that harbors significant difference 
in their PCR product sizes which are scorable on an agarose gel. As indicated in the 
figure, this marker represents a genomic location that has significant size 
polymorphism between AB line and WIK line. (A) When a marker is unlinked with 
the mutation, the AB band and the WIK band should have similar chance to be 
amplified from the mutant pool genomic DNA. (B)  When a marker is on the same 
chromosome but not close to the mutation, the AB band should have a higher 
likelihood to be amplified in the mutant pool genomic DNA in relative to WIK band. 
(C) When a marker is tightly linked (or close) with the mutation, only the AB band 
that can be amplified from the mutant pool genomic DNA. MT: mutant. 
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2.4.3.1 Mapping panel 
The set of genetic marker used for rough mapping (called the mapping panel), was set up 
by Mr. Huang Honghui (Figure 2-3). These 226 pairs of primer harbor length 
polymorphisms called simple sequence length polymorphism (SSLP). They span the 25 
LG at an average of 20 centimorgan (cM) per marker, maximizing the coverage over the 








Figure 2-3 The zebrafish mapping panel used for initial mapping 
The mapping panel is composed of 226 markers confirmed to show polymorphisms 
in our lab by Mr Huang Honghui (unpublished). The markers are distributed on the 






 2.4.3.2 BSA  
The principle of BSA is to use pooled genomic DNA instead of genomic DNA from 
single embryos to test all the markers in the mapping panel to simplify the hunting 
process for linked markers. In this protocol, two genomic DNA pools were generated: 
mutant genomic DNA pool and sibling genomic DNA pool. The mutant pool was made 
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up by taking 10 μl DNA each from 24 individually lysed MUTANT embryos. Similar 
aliquot of DNA from each of 24 individually lysed WILDTYPE SIBLINGS was 
combined making up the sibling pool. These mutant and wildtype sibling embryos were 
the offspring of the same mapping pair belonging to the WIKA background. A parallel 
pooling procedure was carried out for the offspring obtained from the mapping family 
harboring the WIKC background (Figure 2-4).  
 
Genomic DNA from AB / WIK A family Genomic DNA from AB / WIK C family




















Figure 2-4 Schematic illustration of genomic DNA pooling in BSA 
Two mutant genomic DNA pools and two sibling genomic DNA pools were used in 
rough mapping. For each family, 24 embryos, each from mutant and wildtype siblings 
were lysed in individual wells in a 96-well plate. A mapping pool was generated by 
combining 10 μl from each of the 24 wells into an eppendorf tube. After processing 
the other family with similar procedures, the resulting 4 pools were then subjected to 
PCR using primers corresponding to the initial mapping panel of 225 SSLP markers to 





The bulk segregation analysis (BSA) strategy used in this work was adapted from an 
established protocol developed by the Zon Lab (http://zon.tchlab.org/) (Bahary et al., 
2004). To perform genome scanning for mutation on possible linked LG, the 226 genetic 
markers and the various sources of genomic DNA (pools and grandparents) were arrayed 
into 96-well format. All PCR reactions was carried out in a total volume of 20 μl 
consisting of the followings: 2 μl 10X PCR reaction buffer (10 X PCR buffer: 0.5 M KCl, 
0.1 M Tris-HCl, 15 mM MgCl2, 1% Triton X-100.), 0.4 μl 20 mM dNTPs, 0.8 μl 10 μM 
of each primer, 1 μl  genomic DNA after lysis and 1.0 μl Taq (“home-made” Taq, Section 
2.2.5), after which was subjected to program: 94°C for 3 minutes; 40 cycles of 94°C for 
30 seconds, 56°C or 58°C (Appendix 1) for 30 seconds, 72°C for 1minute; 72°C for 10 
minutes. All 20 μl PCR product was analyzed on high resolution gel 3.5% MS-8 Agarose 
(CONDA, Cat. No. 8064) in 0.5 X TBE buffer system (10X TBE: 890 mM Tris-base, 
890 mM boric acid, 20 mM EDTA, pH 8.3).  The interpretation of gel results was 
facilitated by the combination of the unique arrangement of the various genomic DNA 
with primers in a 96-well plate during PCR (Figure 2-5) and the use of an 8-channel 
multichannel pipette during sample loading. Subsequently, the 8 different DNA samples 
(2 grandparents, 1 mutant pool and 1 sibling pool, each from WIK A and WIK C 
mapping populations) generated by one primer were loaded side by side for linkage 
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Figure 2-5 Schematic illustration of the experimental layout and output of rough 
mapping 
(A) Genomic DNA pooled from the two mapping pools (generated from crossing 
sq163 with WIK A and C, respectively) and (B) the SSLP markers were aliquoted into 
a 96-well plate as indicated. In such an arrangement, each 96-well PCR reaction will 
yield the rough mapping result from 12 markers, each consisted of two families, 
represented by 8 DNA sample pools. (C) When loaded with an 8-channel multi-
channel pipette, the 8 samples corresponding to one marker will be analyzed side by 
side, as illustrated. WA: WIK A control from the original grandparent used for 
mapping cross; WC: WIK C control from the original grandparent used for mapping 
cross; MP: mutant genomic DNA pool; SP: wildtype sibling genomic DNA pool; red: 
WIK A mapping family; blue: WIK C mapping familiy.  
 
2.4.4 Intermediate mapping 
After locating the mutation to a certain LG with the help of one or two genetic markers 
from the mapping panel, intermediate mapping was initiated. While efforts were 
continuously being invested into the collection of more mutants via WISH, all existing 
SSLP markers within that region were checked with grandparent genomic DNA to select 
those that exhibit noticeable polymorphisms between the 2 grandparents – AB and WIK 
A or WIK C. The newly selected markers were used to test on the genomic DNA 
collected from the individual mapping embryos for the identification of recombinants. At 
the same time, directionality of the mutation was also defined by the reduction of 
recombinant number when tested on a series of markers in line. After the establishment 
of such genetic map delineating the relationship between the mutation and the SSLP 
markers, the remaining recombinants between two closest markers were used for the 
subsequent fine mapping. 
 
2.4.5 Fine mapping and candidate gene approach 
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The sequence information of the nearest existing genetic markers established in 
intermediate mapping was used to locate their physical positions on the zebrafish genome 
(http://www.sanger.ac.uk/Projects/D_rerio/). The returned sequence of overlapping BACs 
(bacterial artificial chromosomes) or contigs (assembly of overlapping BACs) spanning 
that region was in turned used to design additional markers to further narrow down the 
mutation flanked by the two previous ones into a critical genomic region that can be 
characterized at molecular level to identify mutations. The design of novel SSLP markers 
was done manually (visual scanning for repeats) and via software 
(http://danio.mgh.harvard.edu/markers/ssr.html). Markers that proved to be useful were 
exploited to limit the distance further by carrying out PCR on the remaining recombinant 
DNA. Candidate gene approach was initiated when more than one gene was left in the 
critical region that could not be further resolved. Coding regions of all putative genes and 
ORFs (open reading frames) within the region were sequenced systematically for 
mutation identification by comparing genomic DNA or cDNA among 8 individual 
mutants and 8 individual wildtype siblings. 
2.4.6 Genotyping sq163+/- fish or sq163-/- embryos 
Once the mutation was found, the subsequent identification of sq163+/- fish or sq163-/- 
embryos were conducted by PCR on the genomic DNA extracted as described (Section 
2.4.2), followed by direct sequencing on the PCR product (Section 2.2.2). The primers 
used were listed in Table 2-1. Using an annealing temperature of 54°C, the cycling 




Table 2-1 List of primer pairs used for various purposes 
Primer for gene cloning 
Gene Forward Primer (5’-3’) Reverse Primer (5’-3’) 
bms1l-UTRs ctcgagtctagaacagtggagagagtcacgttg ctcgagtacgtatctcgtgcagcgtcatcat 
bms1l-full length acgttctagaagATGgagaagatggagagga ctcgagtacgtatctcgtgcagcgtcatcat 
rcl1 ATGgagtttgaaggttgtag TGAaagcacaccgtgaatgt 
Primer for site-mutagenesis 
bms1l-163 gatttggttcAgatgttgattgat atcaatcaacatcTgaaccaaatc 
bms1l-stop gcaaaggttgctgattAggttctgatgttgatt aatcaacatcagaaccTaatcagcaacctttgc 
Primer for sq163 -/- or +/- genotyping (PCR and sequencing) 
E5 ataccgaattgtccgcgt aacaactctcagttactgtg 
E6R-seq cagacaatatacagttctct - 
 
2.5 Whole Mount in situ Hybridization (WISH) 
2.5.1 Preparation of DIG-labeled RNA probe 
Various endodermal marker constructs were linearized by the appropriate restriction 
enzyme (Table 2-2) and purified by High Pure PCR product purification kit (Roche, Cat. 
No. 11732668001). A 20 μl RNA probe synthesis reaction was reconstituted by adding: 
1.5 μl RNA polymerase (Stratagene, Cat. No. 600111, 600123, 600152), 0.25 μl 
rRNasin® RNase inhibitor (Promega, Cat. No. N251A), 2 μl 10X DIG RNA labeling mix 
(Roche, Cat. No. 11 277 073 910), 4 μl 5X reaction buffer, 1 μg linearized plasmid DNA 
or 100-200 ng PCR product and nuclease free water. The reaction mixture was incubated 
 77
at 37°C for 2 hours. By the end of the reaction, the DNA template was removed by 
incubation with 1 μl RNase-free DNase I (Roche, Cat. No. 10 776 785 001) at 37°C for 
15 minutes. The synthesized probes were purified via a LiCl-ethanol precipitation method 
as described in the manufacturer’s instructions. However, for some special RNA probes 
requiring higher quality, another purification protocol using a M-30 microcon (Millipore, 
Cat. No. 42410) was used before a LiCl-ethanol precipitation. During this extra step, 100 
μl water was mixed with the 20 μl labeled reaction and passed through the membrane at 
10,000 g for 12 minutes at 4°C. The flow-through was discarded and the procedure was 
repeated by adding 100 μl water into the filter where the remains of the probe was.  The 
labeled RNA was eluted by adding 30 μl of water into the filter and spinning it upside 
down in a new collection tube at 3,000 g for 6 minutes at 4°C. After one- or two-step 
purification protocol, the RNA probe was dissolved in RNase-free H2O, an aliquot (1-2 μl) 
was denatured at 65°C for 20 minutes followed by immediate chilling in ice, and then 
analysed on a 1.3% agarose gel to determine its quality and quantity in comparison with a 
RNA Ladder (Invitrogen, Cat. No. 15623-200); the remaining probe was denatured at 
80°C for 10 minutes followed by instant plugging into ice for 10 minutes. Thereafter, it 
was diluted to a final concentration of 0.5-4 μg per ml of WISH hybridization buffer 
[50% Formamide, 5X SSC, 0.92 mM citric acid (pH 6.0), 0.1 % Tween 20, 50 μg/ml 
Heparin (SIGMA Cat. No. H-3400), 1 mg/ml tRNA (SIGMA, Cat. No. R-6750)] and 
stored at -20°C. Prior to use, the hybridization buffer containing probes was prewarmed 




Table 2-2 List of constructs for WISH RNA probes 
Gene Vector Restriction enzyme RNA polymerase 
prox1 pGEM® T-Easy Sma I Sp6 
lfabp pBluescipt II KS+/- Sac II T3 
pdx1 pGEM®T-Easy Nco I Sp6 
insulin pGEM® T-Easy Nco I Sp6 
trypsin pBluescipt II KS+/- Sac II T3 
ifabp pGEM® T-Easy Nco I Sp6 
foxA1 pBluescipt II KS+/- EcoR I T3 
foxA3 pGEM® T-Easy Nde I T7 
gata6 pT7T3 18U Sal I T7 
hhex pGEM® T-Easy Nco I Sp6 
bms1lATG-1433 pGEM® T-Easy Nco I Sp6 
rcl1FL pGEM® T-Easy Nco I Sp6 
 
2.5.2 High-resolution WISH 
All washes were carried out at room temperature unless specified. Egg water containing 
PTU was used for the collection of embryos more than 1 dpf to inhibit pigments 
formation.  For embryos less than 3 dpf, chorions were removed either enzymatically by 
pronase (SIGMA, Cat. No. P5147-5G) treatment (1-2 mg/ml) or physically with needles 
(size 26G). Dechorionated or no chorion embryos were fixed in 4% paraformaldehyde 
(PFA, dissolved in PBS) (Sigma, Cat. No. P6148) at 4°C overnight. The next day, fixed 
embryos were washed three times in PBST (1 X PBS, 01% Tween 20), each for 10 
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minutes to remove PFA. The embryos were then equilibrated in 100% methanol for 10 
minutes and stored in new 100% methanol at -20°C for at least 20 minutes or for later use. 
To recover embryos stored in 100% methanol, the dehydrated embryos were re-hydrated 
in a series of Methanol/PBST solutions (75%, 50% and 25% Methanol/PBST solution), 
each for 5 minutes, and subsequently washed twice in PBST, each for 10 minutes. 
Embryos were permeated by digestion with proteinase K (20 ug/ml, FINNZYMES, Cat. 
No. F-202L) accordingly (Table 2-3). After a brief wash in PBST, the embryos were re-
fixed in 4% PFA for 20 minutes. After two washes of 10 minutes each in PBST, the re-
fixed embryos were pre-hybridized in WISH hybridization buffer at 68°C for 2 hours and 
then transferred to the pre-warmed hybridization buffer with probe (Section 2.6.1) at a 
desired concentration. After overnight incubation at 68°C, the probe was recovered and 
stored at -20°C. The embryos were then washed at 68°C as followed: twice in 2X SSCT 
(300 mM NaCl, 30 mM Sodium Citrate, 01% Tween 20)/50% Formamide, once in 2X 
SSCT/25% Formamide, twice in 2X SSCT and three times in 0.2X SSCT, each for 20 
minutes. After two final 10-minute washes in maleic acid washing solution (MABT) (150 
mM Maleic acid,150mM NaCl, 0.1% Tween 20, pH 7.5) at room temperature, the 
embryos were incubated in blocking solution (1X MAB, 2% Roche Blocking Reagent 
(DIG Wash and Block Buffer Set (Roche, Cat. No. 1585762)) for 2 hours, and then 
replaced with antibody solution (anti-digoxigenin-AP (Roche, Cat. No. 1 093 274) at 
1:5,000 dilution in blocking solution) overnight at 4°C. The next morning, the embryos 
were briefly rinsed with MABT and then washed three times in the same solution, each 
for 30 minutes. Before detection, the embryos were equilibrated three times with 
detection buffer 1 [100 mM Tris HCl pH 9.5, 50 mM MgCl2, 100 mM NaCl, 0.1% 
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Tween 20 (V/V), 1 mM Tetramisole hydrochloride (Sigma, Cat No. L9756)], each for 10 
minutes. The poisonous compound tetramisole hydrochloride was then removed by 
washing the embryos three times with detection buffer 2 [100 mM Tris HCl pH 9.5, 50 
mM MgCl2, 100 mM NaCl, 0.1% Tween 20 (V/V)], 10 minutes each.  After that, the 
embryos were incubated in NBT/BCIP staining solution [1 tablet from Sigma (Cat. No. 
B5655) dissolved in 10 ml water，  0.1% Tween 20) in the dark either at room 
temperature or at 4°C. Staining time was adjusted by monitoring color development. 
When the desired staining was achieved, the reaction was stopped by briefly rinsing the 
embryos with PBST followed by fixing with 4% PFA for 1 hour. Finally, after two 
washes with PBST for 10 minutes each, the stained and fixed embryos were either 
mounted in 100% glycerol for photo taking or in 50% glycerol for storage in 4°C. 
Table 2-3 Duration of Proteinase K permeabilization for zebrafish embryo 








2.5.3 High throughput WISH 
This WISH method was developed for quick identification of mutant embryos. It was a  
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simplified version of High-resolution WISH protocol described in Section 2.5.2. The 
solutions used and the steps up to hybridization were essentially the same as outlined 
previously. Post-hybridization washes were simplified to the followings: two 15-minute 
washes in 2X SSCT at 68°C, three 15-minute washes in 0.2X SSCT at 68°C and one 15-
minute wash in maleic acid washing solution at room temperature. Then, the embryos 
were incubated in the blocking buffer at room temperature for 2 hour, followed by 
antibody binding with a higher antibody concentration of 1:2000 for 2 hours. After two 
20-minute washes and one 10-minutes equilibration, the embryos were stained until 
desired color development was reached.  
 
2.6 Microinjection 
2.6.1 Preparation of injecting materials 
Before microinjection, morpholino or in vitro synthesized mRNA was diluted with 
distilled water and phenol red (0.5% in DPBS, Sigma, Cat. No. P0290) to obtain desired 
concentrations. Phenol red was used to monitor the injection process visually. Capped 
mRNA was synthesized by in vitro transcription according to the description in Section 
2.3.5. Gene-specific morpholinos and the zebrafish standard control morpholino were 
designed and synthesized by Gene-Tools (www.Gene-tools.com). The sequence of 
morpholinos used in the project was summarized in Table 2-4. Mopholinos were 
dissolved in 1X Danieau buffer (58 mM NaCl, 0.7 mM KCl, 0.4 mM MgSO4, 0.6 mM 
Ca(NO3)2, 5.0 mM HEPES pH 7.6) or distilled water as a 5 mM stock and then aliquoted 
into 10 μl for storage at -20°C. 
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Gene Morpholino sequence (5’-3’) Concentration 
(1nl per injection) 
bms1l ctcttttgcggttacagtttattta 0.75 nmol/ul 
Table 2-4 Sequences of gene specific morpholinos  
 
2.6.2 Preparation of injection needles and embryo supporters 
The injection needles were made from borosilicate glass capillaries with an internal 
filament (10cm length, O.D. 1.0nm, I.D. 0.58mm) (Sutter Instrument, Cat. No. BF100-
58-10). First, the glass capillaries were snapped by the micropipette puller (Sutter 
Instrument, P97 flaming/brown micropipette puller) and then a sharp tip with an outer 
diameter of about 20 μm was cut on the pulled shank of the needle by fine forceps or a 
surgical blade under a dissection microscope. To prepare the agarose moulds for embryos 
arrangement, 3% agarose (normal grade) in egg water was melted and cooled to 60°C. 
This 60°C agarose medium was poured on a petri dish (about 20ml per 90mm petridish), 
and a special plastic mold was laid on the surface of the molten agarose. After removing 
this plastic mold from the solidified gel, small wedge-shaped holes or long furrows were 
used to bed the embryos for injection. These agarose supporters can be kept at 4°C for up 
to 2-4 days. 
 
2.6.3 Microinjection 
Before microinjection commenced, the balance pressure was adjusted to 0.2-0.4 psi to 
prevent flow back of medium into the needle, hence diluting and contaminating the 
injected sample. After arranging the newly laid 1-cell stage zebrafish embryos onto the 
small wedge-shaped holes or furrows on the agarose supporters prepared earlier, the 
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transcripts or morpholino at the desired concentrations was filled into the needle by a 
microloader (Eppendorf Cat. No. 5242 956 003). The needle was carefully extended 
through the chorion and quickly pierced into the yolk, followed by an immediate stepping 
onto the pedal to release the injection sample. The injection volume was less than 2 nl, 
which can be measured by a calibration ruler. Injected embryos were incubated at 28.5°C.  
 
2.7 Immunochemistry 
2.7.1 Cryosectioning of zebrafish embryos 
Bits of the tail section of embryos were cut for genotyping before fixation. After fixing in 
freshly prepared 4% PFA (dissolved in PBST) at room temperature for 2 hours or 4°C 
overnight, zebrafish embryos were washed twice in PBST (1X PBS with 0.1% Tween 20), 
each for 10 minutes, before being mounted onto a small chamber with freshly prepared 
1.5% agarose (Bio-Rad, Cat. No. 161-3102) in 30% sucrose PBST solution. The 
solidified blocks were trimmed to a pyramid shape with head positioned at the top of the 
pyramid. These trimmed blocks were equilibrated in 30% sucrose PBST solution 
overnight at 4°C followed by embedding with O.C.T. compound (Sakura Cat. No. 4583) 
using plastic molds. The whole set up was frozen in dry ice or liquid nitrogen. The frozen 
O.C.T. blocks were sectioned immediately or stored in an airtight box in -80°C for up to 
3-6 months. Prior to cryosectioning, the frozen blocks were mounted on the pre-chilled 
supporter (Leica, Cat. No. 0.370.08587) with O.C.T. compound and equilibrated in a pre-
chilled microtome (Leica, HM505) at -30°C for 2 hours. Sections were cut serially at a 12 
μm thickness and then collected on polylysine coated glass slides (Menzel, Cat. No. 
J2800AMNZ). The slides with sections were de-hydrated by 2 hours or overnight 
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incubation on a hot plate at 42°C. After that, the slides were used immediately for 
antibody staining or stored in airtight moisture protected chambers at -80°C for at least 3 
months.  
 
2.7.2 phospho-Histone H3 Immunostaining  
Sectioned samples were fixed in 2% PFA for 20 minutes and washed three times of 20-
minute each in PBST. Samples were blocked in 4% Bovine Serum Albumin (BSA) for 30 
minutes and incubated with primary antibody against phospho-Histone H3 (Santa Cruz, 
Cat. No. sc-8656R) at a dilution of 1: 200 for 1 hour at room temperature or overnight at 
4°C. Five times wash of 20-minute each were followed by to remove excess antibody. 
The fluorescence-conjugated second antibody, Alexa Fluor® 568 goat anti-rabbit IgG 
(H+L) (Molecular Probes, Cat. No. SKU# A-11011) was applied to sample at a dilution 
of 1 : 400 for 1 hour at room temperature or overnight at 4°C. After the removal of excess 
antibody by similar washing conditions used to get rid of the first antibody, the samples 
were mounted for imaging.  
 
2.8 Microscopy and picture capturing 
LEICA MZ75 stereomicroscope was used for daily injection and embryo development 
monitoring. In situ pictures were captured by an Olympus DP70 camera under Olympus 
MVX10 stereomicroscope. Images of section with fluorescene antibody were taken by 






Chapter 3 Isolation of sq163 
 
As discussed in Chapter 1, one of the most important advantages of zebrafish as a model 
organism is its feasibility to carry out large scale genetic screen and in the context of 
development, the organism is particularly suitable for the dissection of liver 
organogenesis. Therefore, armed with the motivation to explore the underlying molecular 
mechanisms governing liver development in zebrafish, one of the initiatives pioneered in 
the lab was to carry out one such screen to identify liver defective mutants. Before 
addressing the results obtained from my project on the mapping and characterization of 
sq163, this chapter begins with a brief introduction on the groundwork laid down by 
others in the lab that leads to the generation and identification of sq163. 
 
 
3.1 Identification of sq163 by large-scale phenotypic screening 
3.1.1 Forward genetic screen  
The scheme for the screen, with some modifications from the classic protocol (Haffter et 
al., 1996), is summarized in Figure 3-1. Seven ENU mutagenized males (local AB, 
wildtype strain) were mated to wild-type females to generate F1 progeny which is 
heterozygous for one mutagenized genome. Less than 150 F1 fish from each founder 
were collected to breed to avoid spermatogonial clones, and about 700 F1 fish were 
generated. F2 families were raised from intercrossing these F1 (instead of crossing with 
wildtype) due to space constraint. In this way, a mutation (m) present in one of the F1 
parents would be shared by 50% of the fish in the F2 family. Eggs were collected from 
random mating between F2 sibling fish. If both parents were heterozygous for a mutation, 
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1/4 of the eggs is expected to be homozygous mutant and will show the mutant 
phenotype.  A total of 1481 successful sibling crosses from 262 F2 families had been 
screened via an optimized, large-scale in-situ hybridization protocol, which was 
developed for output scoring on 3dpf embryos. Being strongly expressed in the zebrafish 
embryonic liver from 1.5 dpf to 4 dpf as mentioned previously (Section 1.3.3.3), prox1 
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Figure 3-1 Scheme of genetic screening 
Mutangenized founders were crossed with wildtype fish to generate F1. F1 fish from 
the different founders were self-crossed to produce F2 families. F2 mutants were 
identified by in situ hybridization screening. Two rounds of outcross were applied to 
purify the genetic background and to eliminate unstable mutations. F4 mutants were 
mapcrossed with WIK wildtype to generate mapping families for positional cloning.  
 
3.1.2 sq163 confers  a small liver phenotype  
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The result of the screen performed by Huang et al. was summarized in Table 3-1, where 
stable mutants (4th generation) were categorized into 3 main groups after subjected to 3 
rounds of out-crossing with wildtype to clean up their background of residual unwanted 
mutations.  
Category Phenotype Number of line
A Normal morphology, liverless 2 
B Normal morphology, small liver 17 
C Abnormal morphology, liverless or small liver 43 
D Normal morphology, liver on right side of body 4 
Table 3-1 Summary of genetic screening 
ENU mutants obtained after 3 rounds of backcrossing for genetic background purification 
are categorized based on their liver size. Subsequently only categories A and B were kept 
for gene cloning and characterization.  
 
 
Among the mutants obtained, only 19 lines were eventually kept from group A and B for 
their relatively specific liver phenotype. Allelism test has been carried out on these 19 
lines suggesting that they are unique individuals. Together with 16 others, sq163 was 
found to exhibit smaller liver with overall normal morphology, harbouring only about 1/4 
of the wildtype liver size (Figure 3-2, courtesy from Mr Huang Honghui).  
Since it was shown previously that apart from defective endoderm, no other segregatable 
contaminating phenotype was observed in the third round of screen, it is believed that the 
liver phenotype displayed in progenies from these F4 mutants of sq163 were genuine 
results of responsive mutation, rather than those caused by non-specific genetic 
background. With sufficiently pure genetic background, the 4th generation heterozygous 
mutants were used to outcross with wildtype AB for line maintenance and mapcross with 
WIK A and WIK C for the generation of mapping families for positional cloning. With 
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that initiation, I started my project – the positional cloning and characterization of sq163, 






Figure 3-2 Phenotypes of sq163  
sq163 was identified among 19 mutants (Table 3-1) that exhibits a small liver 




3.2 Positional cloning of sq163 
3.2.1 Introduction 
Owing to the nature of mutagen ENU, the liver mutants on our hands likely harbor point 
mutations randomly across any of the 25 linkage groups (LG) in the zebrafish genome, in 
equal probability. The objective of positional cloning, as the name suggests, is to clone 
the mutation by positioning it onto a critical region of one chromosome. It is a map-based 
approach that relies heavily on the recombinant relationships of genetic markers during 
meiosis. One of the consequences of meiosis is the exchange of chromosomal segments 
between homologous chromosomes, of which in turn can be exploited to calculate the 
recombination frequency, hence the distance between two loci. This is logical because the 
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closer a distance between two loci, the less likelihood of DNA breakage occurring in this 
region on the chromosome during meioses, therefore the less chance that they will be 
separated into further locations (Figure 3-3C). Thus, the eventual aim of positional 
cloning is to search for loci that are close to the mutation and then monitor the number of 
recombination events between these loci and the mutation. Technically, there are 3 pre-
requisites to keep track of such events: 1) polymorphic mapping populations that harbor 
the mutant (on the AB chromosome) and wildtype (on the WIK chromosome) in their 
individuals and 2) a panel of polymorphic markers that can differentiate these two 
sources of genetic material and 3) a protocol that makes use of these two and produces a 
comprehensible output.In zebrafish, mapping families with polymorphisms between 
homologous chromosomes are created by introducing a copy of the genome from 
polymorphic line WIK into the mutant in AB background and this is achieved by crossing 
heterozygous AB mutant with wildtype WIK (Figure 3-3B). Simple sequence length 
polymorphism (SSLP) marker is one of the most widely used systems to detect 
polymorphisms between homologous chromosomes. They are sets of primer pairs 
designed to amplify microsatellite repeats (CA or other low complexity sequences) in the 
genome. Polymorphisms between these markers are reflected by length difference when 
PCR products are analyzed by gel electrophoresis (Figure 3-3A).  Since positional 
cloning is a map-based approach, genetic maps with highly dense and evenly distributed 
polymorphic markers are desirable. The first genetic linkage map in zebrafish was 
reported by Postlethwait et al. with 401 random amplified polymorphic DNAs (RAPDs) 
and 13 SSLPs, spaced at an average interval of 5.8 Centimorgans (cM) (Centimorgan is 
the unit of genetic distance, and one centimorgan is defined as one recombination among 
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100 meioses. Since one mutant has two meiosis, one centimorgan is also calculated as 
one recombination among 50 mutants) (Postlethwait et al., 1994). Subsequently, two 
maps with much higher density were established in the Fishman’s lab 
(http://zfrhmaps.tch.harvard.edu) and Zon’s lab (ZonRHmapper/Maps.htm) (Shimoda et 
al., 1999). Since no isogenic line is available in zebrafish, these mapping panels though 
reputable, could not be applied directly onto our mapping populations. Therefore a 
unique panel consisting of 226 pairs of SSLPs (Section 2.4.3.1), compiled from the 
Fishman’s and Zon’s marker lists, was kindly set up by Huang et al. in accordance to the 
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Figure 3-3 Analysis of meiotic recombination by SSLP  
(A) Simple sequence length polymorphisms (SSLP) based on different number copy 
of CA repeat is scorable by electrophoresis easily. (B) Mapcross is carried out to 
introduce WIK background into mutant that harbours AB background. (C) 
Recombination induced during meiosis results in three kinds of mutant genetic 
backgrounds as revealed by the pattern of SSLP marker M. A and a, wild type and 
mutant locus respectively. Red, WIK background; Black, AB background 
 
BSA (Bulked Segregant Analysis) is a method routinely used for initial mapping in 
zebrafish (Shimoda et al., 1999). Figure 3-4 depicts the working principle of BSA. DNA 
pools of homozygote mutant embryos and their siblings are tested respectively with each 
marker in the initial mapping panel to determine the marker that is closely linked to the 
mutation. In the mutant pool, the chromosomes harboring the mutation are in AB 
background except a small portion of them which are from recombined WIK fragments; 
while the sibling pool is a mixture of AB and WIK chromosomes. Thus, markers close to 
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Figure 3-4 Schematic illustration of mapping linkage by BSA 
Mutant and sibling DNA pools are used as PCR template. Four kinds of chromosome 
(WIK background and AB background, recombinants and non-recombinants) exist in 
sibling DNA pool, making both SSLPs from two backgrounds equally amplifiable. 
Majority of the mutant chromosomes in the mutant pool is in AB background. 
Therefore a closely linked SSLP marker like M would produce an AB band with no or 
very weak WIK band in the mutant pool, due to rare recombination of tightly linked 
locus. An unlinked or loosely linked marker, N, in addition to the AB band, would 
have certain recombination probability of the WIK band in the mutant pool hence 
yielding 2 bands. A and a, wild type and mutant locus respectively. Red, WIK 
background; Black, AB background.
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The weak WIK band is due to small portion of WIK DNA against large fraction of AB 
DNA in the mutant DNA pool. However, both AB and WIK bands are expected to be 
amplified with similar intensity when using the sibling DNA pool because of comparable 
AB and WIK DNA ratio in the pool. On the other hand, markers unlinked to the mutation 
would produce both AB and WIK bands with both sources of DNA pool due to 
Mendelian random segregation of unlinked loci. In addition, similar pattern will be 
observed for markers which are far away from mutation in the same chromosome 
because of frequent recombination between the mutation and these markers. Based on 
this principle, only markers closely linked to the mutation will reveal a difference in 
patterns between mutant pool and sibling pool. The 226 markers on our initial mapping 
panel were selected in such way that by spanning at an average 20 cM interval over the 
25 chromosomes, at least one marker will be revealed by BSA to be closely linked to the 
mutation upon scanning the whole genome. The proximity of these markers and the 
mutation can be confirmed by further analysis of these identified markers on individual 
homozygous mutant (instead of pooled DNA). Upon identification and confirmation of 
the markers, subsequent steps include fine mapping and chromosomal walking (also 
known as intermediate and high resolution mapping respectively) to define a small 
critical region harboring the mutation. Finally, DNA sequencing is performed to identify 
the exact mutated nucleotide in the candidate gene.  
 
3.2.2 Generation of sq163 mapping families 
sq163 was generated in the AB line. In order to create mapping families, two 
heterozygous pairs (163-5 and 163-10) from the 4th generation of sq163 were used to 
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cross with two wild-type WIK pairs (WIK-A2 and WIK-C5). In total, four mapping 
families were generated (163-5 ♂ X WIK-A2 ♀, 163-5 ♀ X WIK-A2 ♂, 163-10 ♂ X 
WIK-C5 ♀, 163-10 ♀ X WIK-C5 ♂). Upon maturity, sibling crosses were set to identify 
sg163 heterozygous fish and positive ones were kept as individual mapping pairs 
(parents). Zebrafish individuals are highly heterogenous and the extent of polymorphisms 
between an AB individual and a WIK individual exists in an individual-dependent 
manner. The purpose of generating multiple mapping families is to explore the genetic 
discrepancy in zebrafish to maximize the use of polymorphism in different individuals 
and meanwhile to reduce the risk of encountering less polymorphic AB and WIK parents 
and to avoid the problem of sex-biases. Indeed, in our case, only the progenies from 
sq163 x WIK C showed high polymorphisms and thus were used to generate 
homozygous mutant embryos for the mapping of sq163.  
 
3.2.3 Initial mapping of sq163 
To identify markers closely linked to sq163 by BSA, DNA from 26 homozygous mutant 
embryos and 26 wildtype siblings from the same mapping families were pooled 
respectively. Instead of the anticipated 8 as outlined by the protocol, only 4 DNA samples 
consisting of AB, WIK C, mutant pool and wildtype sibling were used as PCR templates 
for each of the 266 SSLP markers, since only the DNA isolated from progenies of the 
AB/WIK C background showed scorable polymorphisms for most markers.  Marker 
Z4830 on linkage group 12 was found to display different patterns between mutant pool 
and sibling pool in BSA, suggesting that this marker is closely linked to mutation sq163 
(Figure 3-5A).  
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 Figure 3-5 sq163 maps to LG12 by Z4830  
 (A) BSA showed that the mutation is closely linked to the marker Z4830 on linkage 
group (LG) 12 where the PCR patterns of mutant and sibling pools were different and 
the mutant pool amplifying solely the AB band. (B) No difference was found between 
mutant and sibling pools using non-linked marker Z22103 (D) The linkage of 
mutation to Z4830 was verified by performing separate PCR on the 26 individual 
mutants. As expected, majority of the mutants (22/26) showed only AB band except 
for rare recombinants (4/26) (black arrow), displaying both AB and WIK band. (C) 
Z10225, a north marker of Z4830 was also found to be linked to the mutation. (E) 
Upon individual PCR on the same 26 mutants subjected to Z4830, Z10225 showed 
solely AB bands in majority of the individuals and shared the same recombinants with 
Z4830, with three extras, as indicated with red vertical arrows.  Blue arrow: WIK 
band; red arrow: AB band; black vertical arrow: recombinant. AB: AB grandparent 
heterozygote mutant fish; WIK: WIK C grandparent fish; MP: mutant pool and SP: the 
corresponding sibling pool obtained from the same family.   
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Examination of individual embryos revealed that the mutation indeed was linked to this 
marker by showing sole AB band in 22 out of 26 mutant embryos. The remaining 4 were 
recombinants showing both AB and WIK bands (Figure 3-5D). Locating immediately 
north of Z4830, marker Z10225, was also found to be linked to sq163 by showing 
exclusive AB bands in majority of the samples (21/26) upon individual PCR analysis of 
the 26 mutants (Figure 3-5C and 3-5E). Therefore, initial linkage analysis with these 2 
SSLP markers from our mapping panel has placed the location of sq163 onto 
chromosome 12. Furthermore, the fact that Z4830 shared most of the recombinants with 
Z10225 but had one recombinant less than Z10225 suggested that sq163 lies south of 
Z4830, hence defining the marker as the north border of the mutation (Figure 3-6). It 
would have been ideal if the marker Z22103 located just south of Z4830 exhibit similar 
linkage yet having a different set of recombinants out of the 26 samples. This would have 
very quickly positioned the mutation to a limited region, bound by Z4830 and Z22103, at 
the north and south borders respectively. However, Z22103, like the rest of the 224 
markers, did not show any pattern of linkage (Figure 3-5B). Subsequently, our next tasks 
were to find a south marker linked to sq163 and to identify more recombinants for both 
north and south markers to define the position of sq163.  
 
3.2.4 Intermediate mapping 
Known SSLP markers south of Z4830 in high density genetic maps established by 
Fishman’s lab (http://zebrafish.mgh.harvard.edu/zebrafish/index.htm) were selected for 
polymorphism test on the AB and WIK C DNA and those that displayed clear 
polymorphisms and linkage were selected. One of them, Z4397, was found to locate on 
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the different side of the mutation by having independent recombinants from Z4830, 
hence defining it as the south border. Screening with this marker identified 2 
recombinants out of 1831 mutant screened. At the same time, before the identification of 
a closer north marker, recombinants screening carried out with the north boarder, Z4830, 
yielded 63 recombinants out of 1930 mutant embryos. Due to the lack of known south 
markers and few recombinants (which suggests that Z4397 is already very close to the 
mutation), efforts were focused on fine mapping from Z4830 southwards. Subsequently, 
the recombinants of Z4830 were reduced step by step by a series of markers from 63 to 6 
(Figure 3-7A).  
This gradual elimination of shared recombinants by a continuous string of markers 
strongly supports the directionality of sq163 as determined earlier by only two markers 
during rough mapping. In addition, the identification of more informative south markers 
has also resulted in a step closer to the mutation, making Z35706 the new recombinant 
screening north marker.  With that, 16 new recombinants from 2208 mutant embryos 
were picked up making the final statistic to 30 recombinants out of 3538 using Z35706. 
Subsequently, fc06f12.9 took over Z35706 to become the closest informative marker that 
lies just north of the mutation (Figure 3-7B). However Z35706 remained as the 
recombinant screening marker because fc06f12.9 is too close to the mutation that one 
might not obtain recombinants to work on for direction confirmation, which is a crucial 
checkpoint throughout fine mapping.   
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 Figure 3-6 sq163 lies southwards of Z4830 on LG12  
BSA showed that the mutation is closely linked to the marker Z4830 and Z22103 on 
linkage group 12. Upon subjected to individual PCR analysis on the same set of 26 
mutant DNA, Z4830 and Z10225 shared 4 recombinants with Z10225 yielding one 
extra one. This suggests that mutation lies southwards (downstream) of Z4830. Red: 
markers showing linkage; black: markers showing no linkage; arrow: the direction for 
subsequent mapping; CM: centimorgan; SSLP: simple sequence length 
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Figure 3-7 sq163 is bound by Z4830 in the north and Z35706 in the south on LG12 
(A) South boarder marker Z4830 identified 63 recombinants from 1930 mutant embryos 
screened. Subsequent markers southward gradually reduced the 63 recombinants down 
to 6, confirming the directionality of sq163 determined earlier. A south boarder marker 
Z4397 was found to lie on the other side of the mutation by picking up two independent 
recombinants from 1831 mutant embryos. These position sq163 in a region bound by 
Z4830 (north) and Z4397 (south). (B) Further screening of another 2000 mutants with 
Z35706 lead to the identification of more north recombinants totaling the number of 
recombinants up to 30. Red: linked markers in the north; red, bold: linked markers in the 
north revealed by initial mapping; blue: linked marker in the south; black: unlinked 
markers; numbers in parenthesis: number of recombinant / number of mutant embryos 
screened. CM: centimorgan; SSLP: simple sequence length polymorphism. Diagram is 
not drawn to scale. 
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3.2.5 Fine mapping and chromosomal walking on BAC contig 
At this point, with the exhaustion of existing known markers on the linkage map, new 
SSLP markers are essential to further limit the number of recombinants from both 
directions in order to define a workable region for mutation screening, since the distance 
delimited so far by the two boarder markers, about 5 MB is still far too big. A search in 
the Ensembl database (http://www.ensembl.org/Danio_rerio/index.html) and Genome 
Fingerprinting Project database (http://www.sanger.ac.uk/Projects/D_rerio/WebFPC/ 
zebrafish) locked both of the known markers, Z4397 and fc06f12.9 onto one BAC contig, 
contig 1189, which in turn is composed of 219 overlapping BAC clones, most with full 
sequence available. Marker fc06f12.9 was located on the BAC clone DKEY-145P15 
while Z4397, on clone DKEY-288I10 (Figure 3-8). Based on the BAC sequences in these 
contigs, hundreds of possible SSLP marker suggested either by manual design or with the 
help of a free software (http://danio.mgh. harvard.edu/markers/ssr.html) were tested. One 
marker DKEY-145P15-8 reduced the recombinants of fc06f12.9 from 21 to 1, and this 
remaining mutant DNA maintained as a recombinant when tested for a marker on the 
next BAC, DKEY-17E6-8. The final 2 (north) and 1 (south) recombinants could not be 
reduced further upon assessment with finer north SSLP 214E3-11 and south SSLP 
214E3-1 markers respectively (on CH211-214E3) (Figure 3-8). These two final SSLP 
define a critical region with an estimated physical distance of 155 kb. While such 
distance is still far from a practical size to work on for mutation screening, the 
unfortunate depletion of recombinant DNA due to over-usage for mapping has lead to the 
premature initiation of candidate gene approach. The other option of rescreening for more 
recombinants was not undertaken due to the by now so close proximity of these markers 
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to the mutation, which renders the workload required unrealistic for the amount of time 
spent on mapping alone.  
















Figure 3-8 sq163 maps within 155 kb on contig 1189 
Blasting of Z4397 and fc06f12-9 retrieved contig 1189 consisting of overlapping BAC 
clones for more SSLP design and assessment. The 21 north recombinants were 
reduced to one while the two south recombinants remained. The final north and south 
markers locate the mutation to a critical region of 155 kb.  Red: north markers 
showing linkage; blue: south markers showing linkage; bold red: final north marker; 
bold blue: final south marker. Parenthesis defines the critical region where sq163 lies. 
Vertical lines: overlapping BAC clones. Diagram is not drawn to scale. 
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3.3 Candidate gene approach of sq163 
Blast search against the zebrafish genome sequence in the Ensembl database showed that 
this 155 kb genomic fragment contains 5 open reading frames (ORFs) encoding for: G-
protein coupled receptor Gpr123 (gi125831439), zinc finger CTCF (gi125831441), 
Mxtx2 (gi24371281), Bms1l (gi125831426) and SH2-like (gi125831443). Without any 
slight hint suggesting an involvement with endoderm, systematic exons sequencing was 
embarked in these genes in hunt for mutation.  
 
3.3.1 sq163 alters a conserved domain in bms1l 
Consisting of 23 exons, exon 5 of the gene bms1l was found to harbor a nucleotide 
change from T to A (Figure 3-9A), resulting in an amino acid substitution from Leu to 
Gln on the 154th amino acid (Figure 3-9B) in the conserved GTPase domain of ribosome 
assembly protein-like (Bms1l) (Figure 3-9C and D). Sequencing the remainder of the 
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Figure 3-9 sq163 introduces an amino acid substitution in a conserved motif in Bms1l 
(A) Sequence trace showing the T to A mutation (shaded yellow) in the bms1l gene in the 
sq163 mutant resulting in a CTG to CAG codon change (underlined cyan). (B) This in 
turn leads to the conversion of a conserved L154 to Q154 (shaded yellow).  (C) A schematic 
diagram showing the structural organization of the Bms1l protein. sq163 lies in the 
conserved GTPase domain changing a leucine to glutamine. (D) Alignment of Bms1l 
proteins from zerbafish (from this study), human (GI:40788900), mouse (GI:39930555) 
and baker’s yeast (GI:6325039), highlighting the conserved GTPase domain (shaded 
yellow). The mutated amino acid is marked asterisk. 
 
Bms11 is a G-domain-containing protein characterized first in yeast (Wegierski et al., 
2001). Proteins showing strong sequence similarity to Bms1l are encoded in a diverse 
range of genomes, including that of Homo sapiens, Drosophila melanogaster, 
Caenorhabditis elegans, Schizosaccharomyces pombe and even Arabidopsis thaliana, 
making it highly evolutionary conserved. The approximately 400 amino acids long N- 
and C- terminal domains (domain N and domain C respectively) are the most conserved 
regions of the proteins (Figure 3-9D), implying functional significance. By exerting 
GTPase activity on the conversion of recruited GTP into GDP, the N-domain has been 
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shown to promote the processing of the 35S pre-rRNA processing at sites A0, A1 and A2 
of the ribosome during the 40S ribosomal subunit biogenesis events (Karbstein et al., 
2005)(Figure 3-10). It is believed that Rcl1, a putative endonuclease, activates Bms1 by 
acting as a guanine-nucleotide exchange factor (GEF) to promote GDP/GTP exchange, 
and that activated (GTP-bound) Bms1 delivers Rcl1 to the pre-ribosomes. Apart from its 
enzymatic functions, the domain has also been reported to recruit and to enhance binding 
affinity of interacting partners like Rcl1 via conformation changes (Karbstein et al., 2005). 
The C-terminal domain on the other hand, contains a GTPase-activating protein (GAP) 
that functions intramolecularly.  Nevertheless, studies on Bms1l so far are limited to the 
role of this protein on ribosome biogenesis, with focus on the GTPase domain, using 
yeast as the model system. The mutation in the GTPase domain of Bms1l in sq163 might 
lead to the inability or reduced efficiency of the GTPase in either the conversion of GTP 
into GDP, or the recruitment of proper partners to constitute overall ribosomal synthesis. 
Subsequently, the presence of defective endodermal organs can either be a direct or 
indirect consequence. An alternative explanation would be a novel function of Bms1l in 
organogenesis, in higher living organisms like zebrafish that has been overlooked due to 
its established investigation in the yeast. The possibility of both hypotheses is discussed 
in section 3.4. 
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Figure 3-10 Bms1l is a key player in ribosomal biogenesis 
The N-terminal domain of Bms1 of yeast which holds the GTPase domain (red 
square) is linked to the C-terminal domain (blue) by a flexible tether (red). (I, II) 
GTP binding enhances the binding of Rcl1 (green) forming a ternary complex of 
Bms1-GTP-Rcl1. The probable conformational changes in Bmsl (red cirlce) aids in 
the recruitment of Rcl1 as well. (III, IV) This association in turn binds tightly to U3 
RNA, which is bound to pre-rRNA, locating the complex to pre-ribosomes (orange). 
(V) Further conformational changes within the Bms1 protein activate the GTPase 
domain. (VI, VII) GTP hydrolysis by the GTPase domain of Bms1 leads to 
dissociation of Rcl1 from GDP bound Bms1 and subsequent dissociation of Bms1-
GDP from U3 snoRNA. Inset: Structural organization of Bms1 highlighting the U3 
and Rcl1 binding sites. Adapted from Karbstein et al., 2005. 
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3.3.2 L154 to Q154 substitution in Bms1l causes small liver phenotype in sq163  
To confirm that the gene identified is indeed the mutated gene that is responsible for the 
mutant phenotype observed, segregation analysis was carried out. After in situ 
hybridization analysis, the genomic DNA from 105 wildtype siblings and 26 mutants 
from the same family were isolated and DNA fragment containing the mutation was 
amplified via PCR and sequenced. For true mutation found, the wildtype siblings are 
expected to show either T/T or A/T and mutant, A/A at the nucleotide of query. Results 
showed that the wildtype siblings exhibited T/T (33/105) and A/T (72/105) at the 
anticipated ratio of 1:2 while A/A genotype was strictly restricted to mutants (Figure 3-
9A).   
 
3.3.3 bms1l mRNA can rescued sq163 small liver phenotype 
To unequivocally prove that the T to A substitution in the bms1l gene is responsible for 
the sq163 phenotype, a complementation test was carried out. The mRNA encoding 
wildtype and mutant bms1l was injected into one-cell-stage embryos independently and 
the embryos were genotyped later after assessing the liver status via in situ hybridization. 
At 5 dpf, 54.4% of the mutants injected with wildtype bms1l mRNA (31 out of 57 
injected mutant embryos examined) had restored the expression of the liver specific gene 
lfabp (liver fatty acid binding protein) fully or partially (Table 3-2) (Figure 3-11). In 
contrast, both the T to A mutant bms1l mRNA and a mRNA harboring a premature stop 
codon failed to rescue the mutant phenotype (0/6 and 0/18 mutant embryos examined, 
respectively) (Figure 3-11). These results definitively prove that the L154 to Q154 




















Figure 3-11 bms1l mRNA can rescue the small liver phenotype in sq163  
The small liver phenotype of the sq163 mutant (mu) was fully or partially rescued by 
the wildtype bms1l mRNA transcript (bms1lwt) but not the T to A mutant mRNA 
(bms1l163) or the mRNA harboring a premature stop codon (bms1lstop). All embryos 
were at 5 dpf and the liver was visualized by lfabp probe. wt: wildtype; black arrow: 
liver; lfabp: liver fatty acids binding protein; dpf: day post fertilization. The numbers 
in blue represent the percentage of embryos in the respective group, with a sample size 
of 60 (for bms1lwt), 6 (for bms1l163) and 16 (for bms1lstop). An amount of 0.75ng of in 
vitro transcribed mRNA (wildtype or mutant) was injected,  
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 mRNA injected into mutant Liver size recovery Full Partial None 
bms1lWT(N=60) 
 21 13 26 
bms1l163 (N=6) 
 0 0 6 
bms1lstop (N=18) 
 2 0 16 
Table 3-2 Summary of sq163 rescue experiment 
More than 50% of the small liver phenotype of sg163 was successfully rescued by the 
injection of wildtype mRNA of Bms1l (bms1lWT), either fully or partially. On the other 
hand, transcripts with either L154 to Q154 mutation (bms1l163) or premature stop codon 




3.3.4 Knockdown bms1l gene phenocopies the small liver phenotype in sq163 
In zebrafish, morpholino mediated gene knock-down is a commonly used approach to 
study gene function. A 5’UTR-blocking morpholino was designed to block the 5’UTR 
region of bms1l preventing efficient transcription of the gene. The small liver phenotype 
observed in sq163 was phenocopied in morphants injected with bms1l-5’UTR where 
100% of the 93 morphants exhibited small liver, a specific phenotype that was not 
detected in any of the 89 embryos injected with a morpholino control (Figure 3-12A). 
The specificity of this morpholino mimicking experiment is further verified by the rescue 
of these morphants by co-injected bms1l mRNA, where more than 80% was fully or 
partially rescued (Figure 3-12B) (Table 3-3). This provides additional genetic evidence 

















bms1l - 5’UTR MO and
Partial rescue
 
 Figure 3-12 bms1l knockdown can phenocopy sq163 
 
(A) The small liver phenotype of sq163 can be mimicked by the injection of a bms1l 
morpholino (bms1l -5’UTR MO). Control morpholino (control MO) did not elicit 
similar phenotype indicating the specificity of the 5’UTR morpholino. (B) Specificity of 
the morpholino is further supported by liver recovery in the morphants through co-
injection of wildtype bms1l mRNA (bms1lwt*). Note that the bms1l wildtype transcript 
here begins with ATG start codon, devoid of 5’UTR region. The morphants were 
rescued to various extents (Table 3-3). All embryos were at 5 dpf. The liver was 
visualized by lfabp probe. The numbers in blue represent the percentage of embryos in 
the respective group, with a sample size of 93. The amount of mRNA and morpholino 
injected were 0.75 ng and 0.75 pmol respectively. 
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 Injected into wildtype Liver size recovery Full Partial None 
5’UTR-MO +  bms1lWT* 
(N = 93) 
 
49 28 16 
Table 3-3 Rescue of bms1l morphants coinjected with wildtype transcript  
More than 50% of the small liver phenotype of bms1l morphants was successfully 
rescued by co-injection of wildtype mRNA of Bms1l (bms1lWT*), either fully or partially. 
N: total number of injected embryos analysed. 
 
3.3.5 Expression patterns of bms1l 
Regardless of what is long known about this ribosomal biogenesis protein, the probable 
role of Bms1l in endodermal formation is supported by in situ hybridization analysis 
using a fragment containing the GTPase domain as a probe on wildtype zebrafish 
embryos, whereby strong specific signals in the various endoderm-derived organs such as 
liver, pancreas and gut were observed (Figure 3-13B). To exclude the possibility of non-
specific signals by other probable GTPase containing transcripts, the probe fragment was 
blasted against the whole zebrafish genome and no other significant hit was found apart 
from bms1l. Probes generated from the middle and C-terminal of the gene also showed 
enriched signals in these organs (data not shown), further validating the specificity of the 
spatial RNA pattern of this gene in zebrafish. For temporal expression, Northern blot of 
wildtype embryos revealed that bms1l transcripts were expressed at similar levels from 
unfertilized eggs (maternal expression) to 5 dpf, indicating that it is needed throughout 
embryogenesis (Figure 3-13A). With relatively non-specific in situ hybridization signal at 
1dpf (Figure 3-13B) which later collate to endodermal region at 2.5 dpf, it is not 
surprisingly if the specificity detected in the latter was contributed by newly expressed 
zygotic transcript, while maternal (adult) transcript is ubiquitously expressed at early 
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stage. Since the first sign of a liver primordium was reported to be visible at 30 hpf (Ober 
et al., 2003; Ng et al., 2005; Wallace and Pack, 2003), it will be interesting to check the 
in situ hybridization signals on embryos collected between this two time points (24 hpf 
and 2.5 dpf). 
 
α-sense         sense
1dpf 2.5dpf












(A) Northern blot showing bms11 expression at early stages of embryogenesis. The 
methylene blue staining of 40S rRNA is used as a loading control. (B) Whole mount 
in situ hybridization using a fragment containing the GTPase domain of the bms1l 
gene as a probe revealed that the transcript is enriched in endodermal organs such as 
the liver (L), pancreas (P) and gut (G). Signals are also detected in the retina. dpf: day 
post fertilization. unf: unfertilized eggs; d: day post fertilization; WT: wildtype.  
Figure 3-13   Embryonic expression pattern of bms1l 
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3.3.6 Knockdown of rcl1  
Unexpectedly, the in situ hybridization analysis of Rcl1, an interacting partner of Bms1l 
in ribosomal synthesis and processing also revealed an endoderm-enriched pattern 
(Figure 3-14), adding to the mystery of such specificity of what appear to be 
housekeeping genes. One straightforward working hypothesis is that in bms1lsq163, the 
interaction (either physical or functional) between Bms1l and Rcl1 has been 
compromised resulting in the attenuated function of the 40S ribosomal biogenesis 
pathway. The small liver phenotype observed in the mutant suggests that full function of 
the pre-ribosomal complex is necessary to liver development in zebrafish. To validate 
this theory, morpholino knockdown of Rcl1 was performed. A small liver phenotype of 
the morphant will have two important implications: 1) the in situ hybridization signals of 
Rcl1 are genuine and 2) the small liver phenotype of bms1lsq163 is most likely a 
consequence of faulty Bms1l in the ribosomal biosynthesis pathway, instead of one of its 
probable novel functions in other pathways. Unfortunately, all of the 3 Rcl1 morpholinos 
designed (one ATG and two splicing) failed to work, holding back further investigation 
of this intriguing issue at the moment. On the other hand, an insertional mutant zebrafish 
line, hi2452T generated by the Hopkins’ laboratory in a large-scale insertional 
mutagenesis project (Amsterdam and Hopkins, 2004) has the viral vector inserted in the 
rcl1 gene. The phenotypes exhibited by the mutant include defective liver and heart. A 
request for this line has already been sent out with the objective to address whether 
deficiency in ribosomal synthesis pathway is the true cause behind the defective 
endodermal development observed in bms1lsq163. With the availability of good antibodies 
or by making tagged constructs in the future, co-immunoprecipitation experiment 
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between Bms1l (WT or bms1lsq163) and Rcl1 offers an additional approach to investigate 
the biochemical consequence caused by the mutation, addressing whether L to Q 
conversion would compromise the physical binding of Bms1l to Rc1l. Alternatively, 
unfavorable conformation change in the GTPase domain following the amino acid 
substitution resulting in the attenuation of its GDP to GTP conversion is also likely to be 
responsible for the defective phenotypes. The biochemical activity of Bms1lsq163 can be 














Rcl1, the interacting partner of Bms1l during ribosomal biogenesis, shows very 
similar expression patterns to bms1l. The rcl1 transcripts are enriched in endodermal 
organs such as the liver (L), pancreas (P) and gut (G). Signals are also detected in 
the retina. Inset: Schematic illustration of the ribosomal biogenesis complex 
highlighting the physical interaction between Bms1 and Rcl1 in yeast. Inset is 
modified from Karbstein et al., 2005. dpf: day post fertilization. 
Figure 3-14 rcl1 shows similar expression patterns to bms1l in zebrafish 
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3.4 Discussions 
3.4.1 Positional cloning of sq163 
The BSA method is routinely used as the first step in positional cloning of mutated genes 
in zebrafish and the initial identification of a linkage group is a crucial step determining 
the success of positional cloning. The mapping panel with 226 SSLPs developed by 
Huang et al. in the lab was proved to be instrumental. In addition to sq163, three other 
liver mutants have been successfully mapped and cloned by colleagues in the lab, 
confirming the usefulness and reliability of the panel established. 
During the later part of mapping, the dependability of publicly available genomic 
resources has proved to be a key factor as well where the recombinant DNA of sq163 was 
depleted faster than expected due to sorting out of the ordering of contigs and BACs 
within a contig. Regardless of the near completeness of the zebrafish sequencing project, 
the misassembly of whole chunk of genomic sequences belonging to chromosome 10 
onto chromosome 12 was encountered, causing confusing recombinant patterns among 
markers. In addition, certain genomic segments have yet to be represented by any BAC, 
rendering sequence information unavailable for SSLPs design. Nonetheless, the efforts 
invested in this part of the project were worthwhile for future mapping of mutants linked 
to this similar locus in LG12.  
Regardless of the technical hiccups came upon, a candidate genes approach has 
successfully identified the mutation in bms1l. Exon sequencing was carried out 
systematically on the 5 candidates residing in the 155kb genomic region defined by the 
last 2 SSLP markers, from G-protein coupled receptor gpr123, zinc finger ctcf, mxtx2, 
Bms1l and finally SH2-like. No mutation was found in all the exons of the 3 genes 
 116
located before bms1l. Since a subsequent T to A change was identified in bms1l, mutation 
screening was not proceeded to the last candidate, SH2-like. Scientifically, sequencing 
should be carried out on all of the short-listed candidate genes (both introns and exons) to 
disprove other mutations, since no genetic data was available to disregard the possibility 
of a co-existing mutation elsewhere that is responsible for the phenotype. Alternatively, 
an allelic mutant of bms1l would have been a strong genetic support by presenting a 
similar small liver phenotype as in sq163. Attempts at the molecular level have also been 
executed by performing Northern blots and real-time PCR comparing the mRNA levels 
between wildtype and mutant for the 5 candidate genes. No significant difference was 
observed, which can be explained by either the disparity, if any, is too subtle, or the 
mRNA was unaffected at all in the first place.  Comparison at the protein level was not 
realistic for 5 candidates because of the lacking of corresponding antibodies. Instead, we 
performed three independent experiments, namely co-segregation analysis, wildtype 
transcript rescue of mutant and morpholino mimicking, providing substantial and 
indisputable evidence to prove that the L154 to Q154 mutation in Bms1l is truly responsible 
for the small liver in sq163. The mutant line sq163 is referred to bms1lsq163 thereafter. 
 
3.4.2 Mutations in bms1l 
Based on close sequence homology, the structure of the G domain of Bms1l has been 
inferred from the closely related eubacterial protein elongation factors EF-Tu (Sanchez 
and Sali., 1998), containing five conserved polypeptide loops designated G1 through G5, 
which form contact sites with the guanine ring or coordinate the Mg2+ ion. Mutational 
studies have shown that certain residue substitution at the loops of Bms1l affected 
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biological activity (Wegierski et al., 2001), hence defining specific amino acids crucial 
for the process. G domain is known to be present in many regulatory GTPases, acting as 
molecular switches in different cellular processes such as translation, protein trafficking 
and signal transduction (reviewed by Bourne et al., 1991). Therefore it is of no surprise 
when a mutated Bms1l resulted in unviable spores that failed to germinate, revealing 
reduced 40S subunits levels in the mutant using polysome profiling method (Wegierski et 
al., 2001). Similarly, bms1lsq163 zebrafish could only live up to 6 dpf. However no 
significant lowering of rRNA was observed on Northern blots (data not shown). One 
probable explanation would be that the slight fluctuation of 40S levels in which the 
mutant is sensitive to was not captured by the blot. Another possibility would be that the 
effect of the bms1l mutation was not manifested through the reduction of 40S level in 
zebrafish. A more sensitive detection method will be needed to address this aspect more 
accurately. 
 
3.4.3 Ribosomal proteins, development and cancer 
Apart from the suggestive in situ signals enriched in endodermal organs, evidence in 
favor of specific functions for bms1l, what seems to be just another housekeeping gene 
was also shown in a recent study. Uechi and co-workers found that out of the 21 
ribosomal protein (RP) zebrafish morphants generated, 7 displayed specific severe brain 
phenotypes where 3 human orthologs are located within chromosomal regions that have 
been linked to brain-associated disease (Uechi et al., 2006). In addition, among the 12 
insertional lines that exhibit elevated cancer incidence of a specific tumor type MPNST 
(malignant peripheral nerve sheath tumors), 11 of them were each heterozygous for a 
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mutation in a different ribosomal protein gene (Amsterdam, et al., 2004). Most 
interestingly, mutation in RPS19, a ribosomal protein gene, in human leads to Diamond-
Blackfan anemia (DBA; Draptchinskaia et al., 1999). Together, these reports are highly 
indicative of the, either direct or indirect, involvement of ribosomal genes in specific 
developmental processes, with unknown functions that await investigations. Most 
importantly, these reports also highlighted the promising future of zebrafish’s ribosomal 
protein mutants to become a model system for human disease and cancer. While such 
anticipation is supported by about 50 articles published so far since 2000 in which 
zebrafish were used as a cancer model (review by Feitsma et al., 2008), more work is 
needed to reveal the potential of bms1lsq163 in providing insights to liver organogenesis 
and possibly disease biology.  While the role of the ribosomal protein gene mutations in 
the manifestation of disease and the progression to cancer remains unknown, a recent 
follow-up work on the 11 insertional zebrafish lines for different ribosomal protein genes 
by Maclnnes et al. puts forward a link between the two. They found that while the coding 
regions remain wildtype and the gene is transcribed with normal overall protein 
production rates in rp +/- tumor cells, p53 protein levels are greatly downregulated 
(Maclnnes et al., 2008). Alterations in the expression and /or activity of upstream p53 
regulators, like arf and mdm2 also could not account for the observed p53 protein loss. 
These intriguing findings propose the existence of a relationship between appropriate 
amount of ribosomal proteins and p53 protein production in vivo in zebrafish, and that 
disruption of this regulation most likely contributes to tumorigenesis.  
One apparent question raised with the identification of bms1l as the gene responsible for 
the specific small liver phenotype in bms1lsq163 is the puzzling regional defects instead of 
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the expected nonspecific developmental defects with widespread phenotypes like those 
observed in the Minutes fly mutants, which were reported to be contributed by 
quantitative deficiencies of RP genes (Lambertsson et al., 1998). One likely explanation 
is due to maternally expressed bms1l that compensates for bms1lsq163 at the early stage of 
embryogenesis. But at a later stage (e.g starting from 3 dpf), the maternal wildtype Bms1l 
proteins are depleted and replaced by the newly synthesized Bms1lsq163 mutant protein. 
Another possible rationalization of the specific liver phenotype against an otherwise 
normal looking embryo in bms1lsq163 is that ribosomal protein genes could conceivably 
display some novel biological function independent of their role in the ribosome and 
inhibition of this function leads to specific consequence such as defective liver 
development. Such speculation is not groundless since individual ribosomal proteins have 
been implicated in a wide variety of biological functions, including cell cycle and 
progression, apoptosis and DNA damage responses (Volarevic et al., 2000; Lohrum et al., 
2003), and it has also been suggested that their roles in these generic processes may arise 
independently of their role in the ribosome itself (Wool 1996; Wool et al., 1996; Soulet et 
al., 2001). Therefore a possible novel function of Bms1l in liver organogenesis cannot be 
ruled out based on the limited data on hand so far. Another probable explanation for the 
selective manifestation of endodermal phenotype by a seemingly housekeeping gene is 
the effect of gene dosage in different tissue types. This may account for one-third of the 
mutated rp that did not give rise to tumors (Maclnnes et al., 2008). This is probably not 
surprising after all since it has been suggested that different tissues have different 
requirements for specific rp dosages hence expressing variable amounts of the same 
transcript (Bortoluzzi et al., 2001).  
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Nevertheless, at this point of time it is tricky to discuss the above reports in the light of 
our observations where liver in bms1lsq163 is smaller, whereby tumorigenesis is typified 
by the overgrowth of tissue. A probable account for the apparent contradiction would be 
that the mutation state of such genes, that is, either heterozygosity or homozygosity is 
being manifested differently. For this supposition, it would be interesting to assess the 
homozygote status of the 12 insertional lines for ribosomal genes originally isolated via 
tumor surfacing in a heterozygote background. On the other hand, the relationship 
between Bms1l and zebrafish liver development is explored by another approach, which 
is via detailed molecular characterization of the mutant itself. The results are described in 
next chapter.  
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Chapter 4 Characterization of bms1lsq163 
4.1 Introduction 
In zebrafish, liver organogenesis begins with the establishment of a population of cells  
gaining competent hepatic cell fate within the ventral foregut endoderm,  instructed by 
Foxa and Gata factors; thereafter, mesodermal signals, including Fgfs, Bmps Wnt2bb and 
retinoic acid induce the specification of hepatoblasts; hepatoblasts then migrate and 
proliferate to form a discrete liver bud; and finally hepatoblasts in the liver bud undergo 
rapid proliferation and differentiation to give rise to bile duct cells and functional 
hepatocytes (Allende et al., 1996; Wallace et al., 2001; Stafford and Prince, 2002; Zaret, 
2002; Duncan, 2003; Field et al., 2003b; Mayer and Fishman, 2003; Chen et al., 2005; 
Holtzinger and Evans, 2005; Ober et al., 2006; Sadler et al., 2007; Shin et al., 2007). 
Genetic screening of liver mutants in our lab was carried out at 3dpf via in situ 
hybridization where the liver and accessory organs are already well-defined and almost 
fully functional. Thus the mutants, including sq163 isolated via no or weak prox1 signals 
logically should harbor mutations that affect any of the processes taking place before 3 
dpf, which include competence acquisition, hepatoblast specification, liver bud formation 
and possibly the initial stage of liver bud expansion. 
In the previous chapter, by a combination of positional cloning followed by candidate 
gene approach, we showed that the small liver phenotype in bms1lsq163 is due to a T to A 
substitution, altering a conserved GTPase motif in Bms1l. The identification of bms1l as 
the mutated gene responsible for the phenotype was also confirmed by 3 independent 
lines of evidence via co-segregation ratio, wildtype transcript complementation and 
morpholino knockdown. Being one of the ribosomal proteins (RPs) in the ubiquitous 40S 
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ribosome biogenesis pathway, it is tricky to explain how mutation in bms1l could result 
in specific cellular changes, contributing to liver defects. Most investigations so far report 
the roles of Bms1l at the biochemical level, where the conversion of GDP to GTP was 
affected in yeast mutant eventually leading to general growth retardation due to the 
under-synthesis of overall 40S ribosomes (Wegierski et al., 2001). Discussion of this 
gene at the cellular and developmental level is almost non-existence, which poses a great 
challenge ahead to ultimately to link the small liver phenotype to Bms1l function(s). 
Before getting into the underlying molecular mechanism in bms1lsq163, it is necessary to 
investigate the defects of liver development in the mutant in details, with respect to which 
element of the liver organogenesis process is affected. Apart from looking into the 
molecular outcome of the mutation, investigation of the biochemical consequence is also 
crucial to provide clues for the analysis of the mechanism. However due to the 
unavailability of suitable antibody and the lack of time for the generation of an in-house 
antibody against zebrafish Bms1l, the assessment of this thesis is confined to the 
phenotypic characterization of bms1lsq163 via molecular markers, as described in this 
chapter. 
To determine the developmental step at which bms1l gene is essential in zebrafish liver 
formation, a panel of markers staining liver and the other accessory organs arisen from 




4.2.1 bms1lsq163 confers a small liver phenotype 
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bms1lsq163 was identified from our lab’s genetic screen for zebrafish mutants that have 
disruptions in liver development using the liver-specific probe prox1 (Ober et al., 2003). 
During the screen, whereas prox1 is strongly expressed in the embryonic liver at 3 dpf in 
the wildtype (wt) zebrafish, the prox1 signal at this site in bms1lsq163 was greatly 
diminished (Figure 3-2). Subsequently the small liver phenotype was confirmed by 
similar signal reduction by the liver specific gene lfabp (Figure 4-1A). Checking trypsin 
(exocrine pancreas) and insulin (islet) expression we found that, while the bms1lsq163  
exocrine pancreas was affected significantly in size (Figure 4-1B), there were no visible 
defects in the islet (Figure 4-1C). The gut of the mutant was also noted to possess 
reduced signal when compared to that observed in the wildtype using the intestinal 
marker ifabp (intestine fatty acid binding protein) (Figure 4-1D). These defects found on 
the 3 major digestive organs in the mutant are reflected more profoundly at 4 dpf where, 
apart from the absence of looping, the mutant failed to form a fully expanded intestinal 
bulb (Figure 4-2C). By 4 dpf the left lobe of a normal liver should have accumulated in 
size comprehensively and extended over to form the right lobe, as observed in the 
wildtype. However the liver in bms1lsq163 experienced drastic growth arrest where the size 
remained the same as that in 3 dpf, and there is no sign of the second lobe (Figure 4-2A). 
The pancreas in the mutant also suffers obvious delayed expansion where the organ failed 
to broaden and lengthen posteriorly as that seen in the wildtype (Figure 4-2B). These 
results indicate that the mutation in bms1lsq163 does not exclusively affect the 
development of the liver but the digestive system. This in turn is suggesting that bms1l 
mutation must have hit an early factor or a cellular pathway that is shared by at least all 
these 3 organs so that the consequence is manifested in all of them. This is not surprising 
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considering the fact that they all arise from the definitive endoderm. To pin-point the start 
of these observable defects, earlier markers were used to assess the status of the earlier 
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 Figure 4-1 sq163 affects several digestive organs  
Wildtype (wt) and mutant (mt) embryos at 3 dpf were harvested for whole 
mount in situ hybridization followed by genotyping. (A) Liver-specific 
marker lfabp shows that the mutant has a small liver. (B) trypsin probe 
shows that exocrine pancreas is also affected while (C) an insulin probe 
reveals no observable change in the islet. (D) ifabp probe shows that the size 
of the intestine is greatly reduced too. Black arrow: liver; red arrow: exocrine 
pancreas; black arrowhead: islet; blue arrow: intestine. lfabp: liver fatty acid 












 Figure 4-2 sq163 shows severe digestive organ hypoplasia 
Wildtype (wt) and mutant (mt) embryos at 4 dpf were harvested for whole 
mount in situ hybridization followed by genotyping. (A) liver-specific marker 
lfabp shows that the mutant’s liver failed to extend from left to right to form 
two lobes like the wildtype. (B) trypsin probe for the exocrine pancreas shows 
that the organ suffered growth arrest that failed to extend posteriorly. (C) 
ifabp probe for the intestine reveals much reduced signal in the gut in the 
mutant. Black arrow: liver; red arrow: exocrine pancreas; blue arrow: 
intestine. 
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4.2.2 bms1lsq163 and hepatic initiation  
One of the earliest events of liver development in zebrafish is competency acquisition 
where the factors foxa1, foxa3, gata4 and gata6 are known to confer endodermal cells 
with competency proper to develop as hepatic cells and then continue to express in the 
endodermal lineage in the early development of digestive organs. (Lee et al., 2005b; Zhao 
et al., 2005). Upon comparing the expression of these 4 early markers in wildtype and 
bms1lsq163 at 2 dpf, it was found that though subtle, the liver bud in the mutant is noticed 
to be smaller than its wildtype counterpart. This suggests although positive signals 
indicate normal acquisition of hepatic fate, the initial liver budding process in bms1lsq163 
is defective resulting in a small liver phenotype as revealed consistently by all the 4 
probes employed. Interestingly, the phenotype of the pancreas appeared to be the most 
drastic where there was little or no detectable expression of foxa1, gata4 and gata6 in the 
pancreatic bud whereas the liver was only slightly smaller (Figure 4.3A-D). Intriguingly, 
unlike the drastic defects as revealed by the foxa1, gata4 and gata6 three probes, a 
pancreatic bud was being picked up by foxa3, showing no evidence of any mutant 
phenotype. One explanation for the apparent disagreement is that although still present, 
the mutant pancreatic cells somehow are not stained by foxa1, gata4 and gata6 due to 
certain uncharacterized alterations caused by the mutation. The validity of these 
preliminary data has to be confirmed and pancreas specific probes such as pdx1 can be 
used to further confirm the status of the organ in the mutant. In addition, at as early as 2 
dpf, the inability of the gut to thicken and loop is apparent. All data at this stage suggests 
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Figure 4-3 sq163 affects budding of digestive organs 
Wild type (wt) and mutant (mt) embryos at 48 hpf were analysed with early 
markers to assess the competency of the endorderm to acquire a hepatic fate. 
(A)  foxa1, (C) gata4 and (D) gata6 show that these genes are expressed 
indicating the capability of the endodermal cell in forming early hepatoblast, 
however early liver and pancreas budding are affected. Defect in gut lopping 
is also observed by (B) foxa3. 
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4.2.3 bms1lsq163 and hepatoblasts proliferation 
The stage following competency acquisition is specification of hepatoblast from 
competent hepatic endoderm cells. prox1 and hhex are two of the earliest markers of 
definitive hepatoblasts (Ober et al., 2006). To determine the status of hepatoblasts in 
bms1lsq163, we examined the expression of these genes at 2 dpf. Consistently, prox1 
revealed a smaller liver bud in bms1lsq163 compared to wildtype (Figure 4-4A), implying 
that the mutant suffers deficiency in sustaining definitive hepatoblast. Surprisingly, no 
noticeable difference was detected in the liver bud between bms1lsq163 and wildtype when 
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Figure 4-4 sq163 affects hepatoblast proliferation  
Wild type (wt) and mutant (mt) embryos at 48 hpf were hybridized with two 
markers to check the status of the process of hepatoblast specification. (A) prox1 
showed smaller liver bud (black arrow) while (B) hhex showed no visible 
difference in the liver bud between wt and mt (red arrow).  
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4.2.4 Mutant hepatoblasts are impaired in proliferation  
Growth is an output after balancing growth and death, or proliferation and apoptosis. A 
direct supposition for the small liver phenotype in bms1lsq163 therefore can be due to 
reduced proliferation of the hepatoblasts. To test this, the P-H3 and TUNEL assay were 
performed to compare the proliferation and cell death status respectively, in wildtype and 
mutants. P-H3 assay is an immunostaining technique using an antibody against the 
phosphohistone-3 protein (P-H3) as a marker of proliferating cells. Since there is a 
considerable size difference between the wildtype and mutant liver at 4 dpf (Figure 4-5A 
and 4-5B), a percentage of P-H3 positive cells against total number of cell in the liver is 
calculated instead of reporting the absolute P-H3 positive cell numbers. Examining 
sectioned embryos at 4 dpf we found that the mutant had approximately three-fold less P-
H3 positive cells than wildtype in the liver region (Figure 4-5C). This preliminary result 
suggests that one of the contributing factors for a reduced size liver observed is the 
impairment of hepatoblast proliferation.  Alternatively or concurrently, the small liver 
phenotype in bms1lsq163 could also be due to increased apoptosis of the hepatoblasts. The 
apoptotic activity in both the wildtype and mutant liver region at 4 dpf will be examined 
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Figure 4-5 sq163 impairs hepatoblasts 
proliferation 
(A) Top left: Immunostaining using a P-H3 
antibody (pink) on 4 dpf wildtype (wt) 
embryo sections. Top right: White field 
image of section. Bottom: Enlarged image 
from the white dotted box from top left 
showing discrete liver cells used for 
counting. DAPI (blue) is used to mark cell 
nucleus. The white dashed line outlines the 
liver. NC: notochord; G: gut; L: liver; Y: 
yolk. (B) Same as (A) but on 4 dpf mutant 
(mt) embryo sections. (C) Quantitative 
analysis of the proliferating cells in (A) and 
(B). Ten wt and seven mt sections across 
the liver per embryo are counted. Three 




In this chapter the molecular consequences of the bms1l mutation have been assessed by 
WISH using various markers specific for the different endodermal structures at different 
time points. Endoderm organogenesis starts as early as gastrulation stage and includes a 
series of cell lineage specification, bud formation, organ expansion, and cell 
differentiation (Zaret, 2002; Wells and Melton, 1999). Originally isolated for having a 
small liver phenotype, probes specific for the two other major endoderm organs, intestine 
and pancreas indicated that defects are manifested in all of the three organs in the 
bms1lsq163, suggesting that Bms1l is an early factor that plays a role in the digestive 
organs. On the other hand, the various extents of phenotype observed in the 3 different 
organs also imply that Bms1l might exert different needs in each since upon mutation, 
pancreas appears to suffer the most. The fact that three of the major organs are formed 
after all means that the growth of these organs is compromised but not totally abolished. 
This is in contrast to liverless mutants like the sq181 cloned by another colleague in our 
lab and the prometheus (prt) by the Stainier’s lab, a liverless mutant due to mutation in 
Wnt2bb, a third mesodermal inductive signal for hepatic specification (Ober et al., 2006).  
Temporally, upon seeing a phenotype at 3dfp, earlier liver markers are used in an attempt 
to locate the trigger of the mutation on the organ. After gastrulation, foxa1, foxa3, gata4 
and gata6  (Odenthal and Nusslein-Volhard, 1998;  Wallace et al., 2001) are hepatic fate 
competency acquisition markers that are expressed in the endodermal lineage in the early 
development of digestive organs. As revealed by the four probes at 48 hfp, all are 
expressed in the digestive system in  bms1lsq163 , suggesting that hepatic fate specification 
from endoderm is likely unaffected by the mutation. The fact that the bms1lsq163 liver is 
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consistently smaller compared to the wildtype indicates that the expansion of the liver 
primordium is considerably affected.  This defect seen in early liver development is 
supported by prox1 staining, where deficiency in the later step of hepatoblast 
proliferation revealed a similarly smaller liver in bms1lsq163. However hhex, another 
marker documented to be staining for definitive hepatoblasts, indicates an apparent 
normal hepatoblast status in the mutant. One possible explanation for this apparent 
contradiction is that these two markers may not stain for the same type of cells, the 
hepatoblasts. Current data supporting both prox1 and hhex being essential for liver bud 
formation is mainly obtained via mutant studies (Keng et al., 2000; Martinez Barbera et 
al., 2000; Bort et al., 2006; Oliver et al., 1993; Sosa-Pineda et al., 2000). The possible 
existence of various populations within the liver bud or neighboring vicinity during the 
budding process, which may differentiate the two probes of prox1 and hhex awaits more 
detailed experiments like immunostaining with specific antibodies.  
While the apparent inconsistent pancreatic bud signal revealed by one of the 4 probes, 
foxa3 needs further validation, data from foxa1, gata4 and gata6 show that interestingly, 
pancreas seems to be more severely affected by the mutation than liver. At the same time, 
insulin shows that there is no observable difference in the endocrine pancreas between 
wildtype and bms1lsq163. The zebrafish pancreas is composed of two tissues, endocrine 
pancreas and exocrine pancreas. The endocrine pancreas originates from the posterior 
pancreas bud while the anterior pancreas bud mainly gives rise to the exocrine pancreas 
(Field et al., 2003a). Studies in has mutant has suggested that the formations of anterior 
and posterior pancreas buds differ temporally and spatially and the differentiation of 
endocrine and exocrine pancreas can be separated in distinct regions (Field et al., 2003a). 
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So far the pancreatic defects in bms1lsq163 have yet to be addressed in detail with initial 
efforts focused on the liver. However with possible specific deficiency in only the 
exocrine part of the organ, bms1lsq163 will be an interesting mutant for the investigation of 
early exocrine pancreas development. A handful of markers can be used for the 
examination of specific defects. Firstly, pdx1 can be used to check specification of 
endocrine and exocrine pancreas in the mutant (Huang et al., 2001; Yee et al., 2001). 
Next, ptf1a/p48, an essential factor for zebrafish exocrine pancreas development, can be 
used as an early exocrine pancreas marker (Zecchin et al., 2004; Lin et al., 2004). The 
later stage of endocrine and exocrine pancreas development in  bms1lsq163 can be followed 
with Hb9 and mnr2a, respectively (Wendik et al., 2004). Owing to the lack of the early 
exocrine pancreas marker and only a handful factors identified to function in exocrine 
pancreas development, this mutant offers a good candidate to decipher the mechanisms 
that regulate exocrine development specifically. 
Previous reports have shown that after competency acquisition at 24 hpf, hepatoblasts 
and pancreatic precursor cells under the first somite thicken to form their respective buds 
at 30 hpf, from which the future liver and pancreas will develop (Ober et al., 2003; Ng et 
al., 2005; Wallace and Pack, 2003). Thereafter, between 30 dpf (thickening) and 48 dpf, 
there exist other major morphological transition stages such as the actual budding itself 
and furrow and duct formation (to separate the accessory organ buds from the main 
esophagus) that can be easily visualized using similar early markers previously employed. 
Therefore a comparison of the expression patterns of foxa1, foxa3, gata4 and gata6 
between wildtype and bms1lsq163 at various time points before 48 dpf will allow us to 
define more finely the initiation of the mutant phenotype manifestation within the early 
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developmental window of liver organogenesis. Likewise, analysis of prox1 and hhex at 
similar earlier time points where the proliferatoin process just initiates would be useful to 
define the point of phenotypes commencement. As for pancreas, the epithelial 
transcription factors, Pdx1, Hb9 (Hlxb9), Ptf1α (pancreas-specific transcription factor 1α 
subunit, also known as p48), Nkx6-1 and Nkx2-2 (low level) are crucial for the correct 
specification of the pancreatic progenitor cells (Ahlgren et al., 1996; Offield et al., 1996; 
Li et al., 1999; Krapp et al., 1996; Krapp et al., 1998; Sander et al., 2000). These early 
pancreatic markers are instrumental to dissect the early stages of the organ in more detail. 
While the characterization work on bms1lsq163 reported so far is still at its infancy and is 
limited to phenotypic examination via molecular markers, a glimpse into a possible 
reason behind a small liver phenotype is due to the impairment of hepatoblast 
proliferation, as revealed by reduced p-H3 as a cell cycle marker. This is in contrast to the 
findings by Opferman and co-workers where in their conditional knockout mouse for S6 
(a ribosomal protein for the 40S subunit), although the S6-deficient liver cells failed to 
enter S phase and proliferate, the livers from fasted mice were capable of increasing cell 
size in response to the re-addition of food despite a deficiency in 40S ribosomes. This 
keystone results place a cell proliferation checkpoint but not one on growth, downstream 
of a deficiency in ribosomal biogenesis (Opferman et al., 2006). A different mechanism 
might be governed by the other ribosomal biogenesis proteins, such as Bms1l. 
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Chapter 5 Conclusion 
 
 
In conclusion, this thesis has reported the positional cloning of liver mutant sq163 
through two parts: the identification of the mutated gene responsible for the small liver 
phenotype and, the preliminary phenotypic characterization of the mutant via molecular 
markers.  
In the first part, positional cloning of sq163 has successfully identified a T to A mutation 
in the bms11 gene, which results in the L154 to Q154 substitution in a conserved GTPase 
motif in Bms1l giving rise to the small liver phenotype. Subsequently, several 
independent genetic approaches including co-segregation analysis, morpholino 
knockdown and wildtype mRNA rescue experiment have confirmed that the L to Q 
mutation is indeed responsible for the small liver phenotype in sq163. 
In the second part, examination of the sq163 mutant using organ-specific molecular 
markers showed that the defect is not confined to the liver where the gut tube also fails to 
thicken and expand into intestinal bulb and the exocrine pancreas experiences growth 
arrest. Interestingly the endocrine pancreas was found to be not affected by the mutation. 
Using earlier markers it was also shown that defects begin as early as 2 dpf, suggesting 
that bms1l is involved in the early process of initiation and budding of digestive organs.  
Whole-mount in situ hybridization showed that bms1l expression in wildtype embryo was 
enriched in the entire digestive ducts and organs including pharynx, pancreas, liver and 
the entire gut tube, a pattern that is consistent with the phenotypes displayed in the 
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mutant. Northern blot using wildtype embryos RNA revealed that bms1l is a maternal 
gene, which most probably explains why homozygous mutants can survive up to 6 dpf. 
Whole-mount in situ hybridization of rcl1, an interacting partner of bms1l in the 
biogenesis of 40S showed that it is also enriched in the digestive organs, favoring the 
notion linking liver development and ribosomal biogenesis pathway. A possible novel 
pathway of Bms1l in tumorigenesis is envisioned based on increasing reports on the 
involvement of ribosomal proteins in promoting organ specific tumor progression upon 
mutation. However, apart from this exciting supposition, there remains a number of 
pressing issues to be addressed.  
The small liver phenotype observed in the mutant suggests that full function of the pre-
ribosomal complex is necessary to liver development in zebrafish. One working 
hypothesis is that the bms1lsq163 mutation in Bms1l compromised the interaction (either 
physical or functional) of Rcl1 to Bms1l, resulting in the attenuated function of the 40S 
ribosomal biogenesis pathway. Therefore both genetic (rcl1 morphant) and biochemical 
(pull-down assay) approaches can be employed to further assess the correlation of 
ribosomal biogenesis pathway with liver development.  
Early hepatic initiation and specification events are found to be affected in bms1lsq163. 
With gastrulation commencing as early as 12 hpf and a series of rigorous physical and 
molecular (i.e. gene expression) signatures and transitions that follows, more temporal 
and spatial markers should be examined in earlier embryos to more finely dissect the 
defects in bms1lsq163. 
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P-H3 assay has shown that one of the factors contributing to small liver phenotype in 
bms1lsq163 is the impairment of hepatoblast proliferation. TUNEL assay will be 
informative to see if this impairment is coupled with apoptosis resulting in the phenotype. 
 
Upon answering those immediate questions, one interesting aspect of the mutant may 
worth further pursue. As mentioned, numerous studies in recent years have offered 
several lines of evidence suggesting that RP mutant genes may be acting as 
haploinsufficient tumor suppressors in zebrafish, hence initiating a link between 
ribosomal protein genes and tumorigenesis. It would be of great interest to see whether 
bms1lsq163 harbors such susceptibility.  
In conclusion, with sq163 conferring apparent early liver defects before 2 dpf while 
another small liver mutant sq198, identifies a gene that is responsible for liver growth at 
the later stage at 3 dpf instead.  The 4 mutants cloned in the lab so far are defective in the 
various aspects of liver organogenesis process. Having the developmental pathway 
defined by the various liver mutants truly reflects the power of forward genetic approach, 
where each step in the process has equal likelihood to be represented by one 
corresponding mutant, at least. It is anticipated that the current knowledge obtained from 
bms1lsq163 will not only fill up some gaps in the complicated process of liver development, 
but further studies will be able to better understand the eventual underlying biological 
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